Original Article
Coronary-Artery Revascularization before Elective Major Vascular Surgery
N Engl J Med 2004; 351:2795-2804December 30, 2004
- Abstract
Background
The benefit of coronary-artery revascularization before elective major vascular surgery is unclear.
Methods
We randomly assigned patients at increased risk for perioperative cardiac complications and clinically significant coronary artery disease to undergo either revascularization or no revascularization before elective major vascular surgery. The primary end point was long-term mortality.
Results
Of 5859 patients scheduled for vascular operations at 18 Veterans Affairs medical centers, 510 (9 percent) were eligible for the study and were randomly assigned to either coronary-artery revascularization before surgery or no revascularization before surgery. The indications for a vascular operation were an expanding abdominal aortic aneurysm (33 percent) or arterial occlusive disease of the legs (67 percent). Among the patients assigned to preoperative coronary-artery revascularization, percutaneous coronary intervention was performed in 59 percent, and bypass surgery was performed in 41 percent. The median time from randomization to vascular surgery was 54 days in the revascularization group and 18 days in the group not undergoing revascularization (P<0.001). At 2.7 years after randomization, mortality in the revascularization group was 22 percent and in the no-revascularization group 23 percent (relative risk, 0.98; 95 percent confidence interval, 0.70 to 1.37; P=0.92). Within 30 days after the vascular operation, a postoperative myocardial infarction, defined by elevated troponin levels, occurred in 12 percent of the revascularization group and 14 percent of the no-revascularization group (P=0.37).
Conclusions
Coronary-artery revascularization before elective vascular surgery does not significantly alter the long-term outcome. On the basis of these data, a strategy of coronary-artery revascularization before elective vascular surgery among patients with stable cardiac symptoms cannot be recommended.
Media in This Article
Figure 1
Long-Term Survival among Patients Assigned to Undergo Coronary-Artery Revascularization or No Coronary-Artery Revascularization before Elective Major Vascular Surgery.Figure 2
Long-Term Use of Medical Therapy in the Revascularization and No-Revascularization Groups at 24 Months after Randomization.Article Activity
- Article
The optimal treatment of patients undergoing elective vascular surgery has not been clearly defined. Because the prevalence of coronary artery disease among these patients approaches 50 percent,1 the incidence of perioperative cardiac complications is high, leading to a rigorous process of risk stratification.2-5 In the absence of any outcome-based studies, panels of experts have recommended that preoperative coronary-artery revascularization be reserved for subgroups of patients with unstable cardiac symptoms or for whom coronary-artery bypass grafting (CABG) offers a long-term survival benefit.6,7 Despite these published guidelines, there is substantial variability among clinicians concerning the recommendations for preoperative cardiac intervention,8 which reflects in part, the absence of any randomized studies.
In support of the aggressive treatment of coronary artery disease before vascular surgery, retrospective data indicate that revascularization improves long-term outcomes.9 In addition, among the cohort of patients from the Coronary Artery Surgery Study with peripheral vascular disease, the survival after 3.5 years in the surgically treated group was better than that in the group receiving medical therapy.10 In support of a conservative management plan, retrospective data from a large registry of patients who had undergone vascular surgery show that procedure-related complications among patients undergoing preoperative revascularization are frequent, often leading to critical delays in the intended vascular surgery.11 Therefore, we undertook the Coronary Artery Revascularization Prophylaxis (CARP) trial to assess the long-term benefit of preoperative coronary-artery revascularization among patients with stable coronary artery disease who are scheduled for elective vascular surgery.
Methods
Study Patients
Patients were eligible for the study if they were scheduled for an elective vascular operation for either an expanding abdominal aortic aneurysm or severe symptoms of arterial occlusive disease involving the legs. The exclusion criteria were a need for urgent or emergency surgery, a severe coexisting illness, or prior revascularization without evidence of recurrent ischemia.12
Coronary angiography was recommended for eligible patients if the patient was considered by a cardiology consultant to be at increased risk for a perioperative cardiac complication. Guidelines for coronary angiography were provided for each site on the basis of combined clinical risk factors and the presence or absence of ischemia on a noninvasive stress imaging study.4 During the study, cardiology consultants were also influenced by other recognized risk factors including a prior stroke, insulin-dependent diabetes, and renal failure,13 as well as by a greater reliance on stress imaging.14
On the basis of the coronary angiogram, a patient was eligible for the study if one or more major coronary arteries had a stenosis of at least 70 percent and were suitable for revascularization. Local investigators decided which revascularization procedure to use, either percutaneous coronary intervention or CABG. Although percutaneous coronary intervention and CABG are considered equivalent before major noncardiac operations,15 the potential long-term advantage of CABG among patients with diabetes and multivessel disease was recognized.16 Anatomical exclusion criteria were a stenosis of the left main coronary artery of at least 50 percent, a left ventricular ejection fraction of less than 20 percent, and severe aortic stenosis.
Study patients were recruited for a 12-month feasibility trial (from August 1997 through July 1998) involving five Veterans Affairs (VA) medical centers. Enrollment for the main study, involving 18 VA medical centers, occurred from March 1999 through February 2003. As planned, the efficacy results from the pilot study were not evaluated at its completion so that they could be combined with the results of the main study. Follow-up ended on February 28, 2004. The human rights committee of the VA Cooperative Studies Program and the institutional review board at each participating VA medical center approved the study.
Randomization and Treatment
We used a stratified randomization process with permuted blocks. The stratification factors were the hospital and, because intraabdominal and infrainguinal operations have different outcomes, the proposed vascular surgery.17 After randomization, we expected the intended procedure (either cardiac or vascular) to be performed within three weeks. If CABG was planned, we expected the vascular operation to occur within three months. If percutaneous coronary intervention was planned, we expected the vascular operation to be delayed for at least two weeks, owing to an increased risk of an in-stent coronary-artery thrombus.18 For three days after vascular surgery, blood was collected and sampled for cardiac enzymes and an electrocardiogram was obtained. Three months after surgery, the left ventricular ejection fraction was determined with the use of radionuclide angiography. All patients who underwent randomization had follow-up visits at the local site every three months for the first year and every six months for the remainder of the study.
Outcomes
The primary end point was long-term mortality and was ascertained through follow-up and by means of the Veterans Affairs Beneficiary Identification and Records Locator Subsystem. Secondary end points included myocardial infarction, stroke, limb loss, and dialysis. Eighty-six percent of patients in the revascularization group and 85 percent of patients in the no-revascularization group had follow-up visits within one year before the end of the study. After revascularization (CABG or percutaneous coronary intervention), myocardial infarction was diagnosed on the basis of a combination of elevated levels of cardiac enzymes and changes in the electrocardiogram. A myocardial infarction after the vascular surgery was diagnosed on the basis of elevated levels of cardiac enzymes and was characterized by associated ischemic changes on the electrocardiogram. The end-points committee, which was independent of the study and blinded to the assigned treatment, validated all outcomes.
Statistical Analysis
We predicted mortality on the basis of the outcomes of patients from the Coronary Artery Surgery Study registry who had peripheral vascular disease.10 A 5 percent one-sided log-rank test was used, indicating that a sample of 559 patients would be needed to provide the study with 90 percent power to detect differences in the 3.5-year survival rates of 75 percent in one group and 85 percent in the other. Because recruitment was slower than expected in the main study, the three-year enrollment period, with a minimal follow-up of two years, was changed to a four-year enrollment period, with a one-year follow-up. Total recruitment was 510 patients (of whom 98 percent were male), who were randomly assigned to one of the two study groups.
Intention-to-treat analyses provided information about survival, from the time of randomization. Survival curves were generated with the use of Kaplan–Meier product-limit estimates, and intergroup differences were evaluated by the log-rank test. The Cox proportional-hazards model was used to calculate estimates of relative risk and 95 percent confidence intervals, comparing treatments within high-risk subgroups of patients. Data are expressed as means ±SD, or as medians with interquartile range when specified. All tests were two-sided.
Results
Screening
Of 5859 patients scheduled for vascular surgery, 4669 (80 percent) were initially excluded. The main reasons were insufficient cardiac risk (1654 patients), an urgent need for vascular surgery (1025), prior CABG or percutaneous coronary intervention without ischemia (626), and a severe coexisting illness (731). The patient's decision not to participate and ineligibility because of participation in other research studies accounted for 633 exclusions. Of the patients who underwent coronary angiography without any clinical exclusions, 680 were excluded for reasons that were specified in the protocol. The primary reason was either nonobstructive coronary arteries (363 patients) or coronary artery disease that was not considered amenable to successful revascularization (215). Other anatomical reasons for exclusion included a stenosis of the left main coronary artery of at least 50 percent (54 patients), a left ventricular ejection fraction of less than 20 percent (11), and severe aortic stenosis (8). Refusal to participate, by either the patient or the referring physician, accounted for 29 exclusions.
Study Patients
Of the 510 patients (9 percent of the 5859 originally screened) who underwent randomization, 258 were assigned to a strategy of preoperative coronary-artery revascularization, and 252 to no revascularization. There were no significant differences in the baseline characteristics of the two groups (Table 1Table 1
Baseline Clinical Variables According to the Assigned Treatment before the Elective Major Vascular Surgery.). According to the criteria of Eagle and colleagues regarding preoperative assessment of cardiac risk,4 28 percent had three or more clinical risk factors, and 65 percent had either three or more clinical risk factors or one or two risk factors with ischemia, as demonstrated on a stress test. According to the Revised Cardiac Risk Index, 49 percent had two or more risk factors, and 13 percent had three or more risk factors.13 Nuclear stress imaging was performed in 316 (62 percent) of the study patients. The size of the reversible defect relative to total myocardial perfusion was determined at each site and graded semiquantitatively as small, moderate, or large. The size of the perfusion defect was moderate or large in 226 patients. Overall, 74 percent of the study patients had three or more of the Eagle clinical criteria, two or more variables defined by the Revised Cardiac Risk Index, or a moderate or large reversible defect on stress imaging. In the majority of the remaining patients, angina or abnormal results on the stress test were the reason for preoperative coronary angiography.Coronary-Artery Revascularization
Of the 258 study patients assigned to preoperative coronary-artery revascularization, 240 (93 percent) underwent either CABG (99 patients) or percutaneous coronary intervention (141 patients). Of the 18 patients who did not undergo preoperative revascularization, 8 (3 percent) required urgent vascular surgery and 9 (3 percent) chose not to undergo revascularization. In one patient, a stroke precluded proceeding with the scheduled CABG. Table 2Table 2
Procedural Characteristics and Postprocedural Complications of CABG and Percutaneous Coronary Intervention (PCI) in 240 Patients Assigned to Undergo Coronary-Artery Revascularization before Elective Major Vascular Surgery. summarizes the results for the 240 patients who underwent CABG or percutaneous coronary intervention as part of the assigned treatment. Of four deaths associated with revascularization, two deaths in the percutaneous-coronary-intervention group and one death in the CABG group occurred after successful revascularization and shortly after vascular surgery. Those three deaths were considered complications of revascularization because they occurred during the same hospitalization period.After randomization, 9 of the 252 patients assigned to undergo no revascularization before vascular surgery (4 percent) required preoperative revascularization because of an unstable change in cardiac status. Seven of them subsequently underwent vascular surgery after revascularization.
Vascular Surgery
Of the 258 patients assigned to undergo preoperative revascularization, 225 (87 percent) underwent the planned vascular operation, as did 237 of the 252 patients (94 percent) assigned to no preoperative revascularization. Of the 33 patients randomly assigned to revascularization who did not undergo vascular surgery, 10 died after uncomplicated CABG or percutaneous coronary intervention, 18 declined the surgery (5 on the advice of the primary physician), and a severe coexisting condition developed in 5. Of the 15 patients randomly assigned to no preoperative revascularization who did not undergo vascular operation, 1 died after urgent CABG, 9 declined (3 on the advice of the primary physician), and a severe coexisting condition developed in 5. Among the patients who underwent vascular surgery, there was a significantly longer time to vascular surgery in the group assigned to revascularization than in the group assigned to no revascularization. In the group assigned to revascularization, the vascular operation occurred a median of 48 days after CABG and 41 days after percutaneous coronary intervention. There were no other intergroup differences in perioperative management (Table 3Table 3
Clinical Features and Outcomes of Vascular Surgery According to the Assigned Treatment before the Elective Major Vascular Surgery.). With the exception of the use of intravenous nitroglycerin, there were no significant differences in perioperative medications.Postoperative Outcomes
Before vascular surgery, there were 10 deaths in the revascularization group and 1 death in the no-revascularization group. Within the 30-day period after the vascular surgery, there were seven deaths (3 percent) in the revascularization group and eight deaths (3 percent) in the no-revascularization group (Table 3). Two of the deaths in the revascularization group occurred in patients who had undergone successful percutaneous coronary intervention but required urgent vascular surgery seven days later. The core laboratory for measurement of cardiac enzymes received blood samples from 88 percent of the patients, and a postoperative myocardial infarction, defined by elevated troponin levels, occurred in 16 percent of those patients; this rate is consistent with the percentage of myocardial infarctions recorded for all patients at the individual sites (Table 3).
Long-Term Outcome
Three months after vascular surgery, the left ventricular ejection fraction was 54±13 percent in the revascularization group and 55±12 percent in the no-revascularization group (P=0.69). The median follow-up time for mortality was 2.8 years (interquartile range, 1.7 to 3.9) in the revascularization group and 2.6 years (interquartile range, 1.6 to 3.8) in the no-revascularization group. There were 137 deaths (70 in the revascularization group and 67 in the no-revascularization group). At a median of 2.7 years after randomization, mortality was 22 percent in the revascularization group and 23 percent in the no-revascularization group (relative risk, 0.98; 95 percent confidence interval, 0.70 to 1.37; P=0.92) (Figure 1Figure 1
Long-Term Survival among Patients Assigned to Undergo Coronary-Artery Revascularization or No Coronary-Artery Revascularization before Elective Major Vascular Surgery.). Among the patients assigned to no preoperative coronary-artery revascularization, 21 (8 percent) underwent postoperative coronary-artery revascularization after vascular surgery. When the analysis was repeated according to treatment received rather than treatment assigned at randomization, the rate of death at 2.7 years was 22 percent of the patients who underwent revascularization (249 patients) and 23 percent of the patients who did not undergo revascularization (261 patients) (relative risk, 0.97; 95 percent confidence interval, 0.69 to 1.36; P=0.86).A Cox regression model used to analyze subgroups of patients with characteristics indicating a high risk showed that coronary-artery revascularization did not impart a survival benefit in any of the high-risk subgroups (Table 4Table 4
Influence of Coronary-Artery Revascularization on Long-Term Survival among High-Risk Subgroups of Patients Scheduled for Vascular Surgery.). Beta-blockers, antiplatelet agents (aspirin or inhibitors of adenosine diphosphate), angiotensin-converting–enzyme inhibitors, and statins were used by the vast majority of patients 24 months after randomization, and their use did not differ between the groups (Figure 2Figure 2Long-Term Use of Medical Therapy in the Revascularization and No-Revascularization Groups at 24 Months after Randomization.).Discussion
The principal finding of this cooperative study at 18 VA medical centers is that, among patients with stable coronary artery disease, coronary-artery revascularization before elective major vascular surgery does not improve long-term survival. Although the study was not designed to test the short-term benefit of prophylactic revascularization, there was also no reduction in early postoperative outcomes, including death, myocardial infarction, and length of the hospital stay. The findings support the opinions of the task force of the American College of Cardiology and the American Heart Association and of the American College of Physicians, which have recommended that CABG or percutaneous coronary intervention be reserved for patients with unstable cardiac symptoms or advanced coronary artery disease, for whom a survival benefit with CABG has been proved.6,7 Despite these published guidelines, there is a lack of consensus among cardiologists regarding the indications for preoperative coronary-artery revascularization,8 which probably reflects the absence of published data.
The results reported here differ from the findings of the prospectively designed Coronary Artery Surgery Study, which showed a survival benefit associated with CABG among patients with severe vascular disease.10 It is unlikely that our failure to demonstrate a long-term benefit with revascularization was a result of procedural complications. The mortality and morbidity associated with CABG and percutaneous coronary intervention in this trial were lower than that in previous reports involving prophylactic revascularization before vascular surgery11 and are more consistent with the expected rates in a general medical population.19 It is also unlikely that our trial failed to detect differences in treatment because of insufficient power. Although enrollment was 9 percent lower than the target sample size and the minimal follow-up was slightly reduced, the follow-up in the patients from the pilot study was longer than expected, and the actual number of deaths in the trial was higher than expected. Therefore, the power of this study, recalculated at a two-sided α level of 0.05, was 90 percent, showing no net loss of power.
We believe our findings can be generalized to a large group of male patients who are considered at increased risk for cardiac complications of elective vascular surgery. Before patients were enrolled in our study, a cardiology consultant at each site initially screened all patients and recommended coronary angiography on the basis of his or her interpretation of the cardiac risk. Analysis of the baseline data showed that at least 74 percent of the study patients would have been considered to be at least at intermediate risk because of either clinical criteria4,13 or results from noninvasive imaging tests showing a high risk.14 The majority of the remaining patients were considered to be at risk because of either an abnormal stress test or the presence of angina, which has been shown to be a risk factor.20 Although the results may help guide preoperative therapy for a broad group of patients with stable cardiac symptoms, they cannot be extrapolated to all patients in need of vascular surgery, particularly those with unstable angina, aortic stenosis, or severe left ventricular dysfunction.
The potential effect of advances in medical therapy since the Coronary Artery Surgery Study cannot be overemphasized. The widespread use of beta-blockers, antiplatelet agents, angiotensin-converting–enzyme inhibitors, and statins in our study population throughout the follow-up period may have improved the outcomes in all patients and diminished the differences in long-term survival between those treated according to an initial aggressive preoperative strategy and those treated according to a conservative strategy. Moreover, in the perioperative period, beta-adrenergic–blocking agents, which have been demonstrated to improve outcomes among patients undergoing vascular surgical procedures,21,22 were judiciously administered to most study patients. This treatment, as well as the use of statins, may have adequately protected the medical therapy group at the time of the vascular surgery.
The intense perioperative management by the study investigators may also have influenced favorably the outcome of the patients who did not undergo revascularization. This management included the perioperative care by the anesthesiologists and surveillance by the vascular surgical team in the early postoperative period. With staff available 24 hours a day in the catheterization laboratory to intervene if necessary, patients with acute coronary syndromes in the present era may have an improved postoperative prognosis. The incidence of postoperative myocardial infarctions was not reduced by coronary interventions, suggesting that the mechanism of cardiac-enzyme release after vascular surgery involves more complex mechanisms than the number of coronary arteries with critical stenoses. There is emerging evidence that postoperative myocardial infarctions are commonly associated with disease progression in vessels with minimal stenosis.23 Incomplete revascularization could be a factor in the lack of protection against postoperative myocardial infarctions, but the completeness of both percutaneous coronary intervention and CABG in the present study were similar to those in previous studies.16
In conclusion, this multicenter, randomized trial shows that coronary-artery revascularization before elective vascular surgery does not alter long-term survival. Although the study was not powered to detect a beneficial effect in the short term, there also appears to have been no reduction in the number of postoperative myocardial infarctions, deaths, or days in the hospital. On the basis of these data, coronary-artery revascularization before elective vascular surgery among patients with stable cardiac symptoms cannot be recommended.
Supported by the Cooperative Studies Program of the Department of Veterans Affairs Office of Research and Development.
This article is dedicated to the memory of William C. Krupski.
Source Information
From the Minneapolis Veterans Affairs (VA) Medical Center (E.O.M., H.B.W., G.P., S.S., C.J.) and the Department of Medicine, Division of Cardiology (E.O.M., G.P.), and the Department of Surgery (S.S.), Division of Cardiovascular and Thoracic Surgery (H.B.W.), University of Minnesota — all in Minneapolis; the Cooperative Studies Program Coordinating Center (T.E.M., L.T., N.E., D.J.R.) and the Division of Peripheral Vascular Surgery (F.L.), VA Medical Center, Hines, Ill.; Southern Arizona VA Health Care System and the University of Arizona Sarver Heart Center — both in Tucson (S.G.); the Denver VA Medical Center, Denver (W.C.K., B.H.); the Department of Surgery (J.R.) and the Division of Cardiology (K.S.), University of California, San Francisco; San Francisco VA Medical Center, San Francisco (J.R., K.S.); and the University of Colorado Health Outcomes Program, Aurora, and the Department of Preventive Medicine and Biometrics, University of Colorado, Denver (W.G.H.).
Address reprint requests to Dr. McFalls at the Division of Cardiology, VA Medical Center, 1 Veterans Dr., Minneapolis, MN 55417, or at mcfal001@tc.umn.edu.
Appendix
Organizational members of the Coronary Artery Revascularization Prophylaxis trial were as follows: Site Investigators — M. Icenogle, M. Langsfeld, S. Pett (Albuquerque, N.M.); K. Mavromatis, A.A. Salam, J.D. Vega (Atlanta); J. Jean-Claude, G. Pinault, J. Ortiz (Cleveland); P. Frenkel, M. Jessen, J.G. Modrall (Dallas); W. Krupski, B. Hattler (Denver); J. Gray, K. Morris, W. Wolfe (Durham, N.C.); R. Kerensky, S. Lind, M. Staples (Gainesville, Fla.); A. Greene, S. Lalka, T. Sharp (Indianapolis); M. Moursi, Y.W. Aude, T. Antakli (Little Rock, Ark.); G. Pierpont, S. Santilli (Minneapolis); S. Muluk, F. Sonel, M. Zenati (Pittsburgh); J. Edwards, G. Larsen, P. Ravichandran (Portland, Oreg.); G. Chilton, E. Sako, M. Sykes, B. Toursarkissian (San Antonio, Tex.); J. Rapp, M. Ratcliffe, K. Shunk (San Francisco); T.R. Kohler, K. Lehmann (Seattle); M. Back, D. Novitzky, M.A. Siddique (Tampa, Fla.); S. Goldman, G. Sethi, A. Westerband (Tucson, Ariz.); D. Baker, R. Ebrahimi, F. Esmailian, B. Singh (West Los Angeles); D. DePinto, F. Littooy, H. Loeb (Hines, Ill.); T. Gavin, K.B. Ramanathan, D. Weiman (Memphis, Tenn.); S. Khuri, G. Sharma (West Roxbury, Mass.); End-Point Committee (confirmed end points on the basis of pertinent hospital records) — K. Weir, R. Kelly, J. Davenport; Cooperative Studies Program Coordinating Center, Hines, Ill. — N. Ellis, T. Moritz, W. Henderson, D. Reda, L. Thottapurathu; Clinical Coordinator — C. Jaenicke; Angiography Core Laboratory (reviewed all angiograms) — K. Weir; Specimen Testing Core Laboratory (validated perioperative cardiac enzymes) — F. Apple (Hennepin County Medical Center, Minneapolis); Good Clinical Practice — C. Haakenson; Study Coordinators — D. Robertson (Albuquerque, N.M.); D. House (Atlanta); G. Webbs (Cleveland); A. Swann (Dallas); W. Klenke (Denver); K. Swails (Durham, N.C.); J. Brown (Gainesville, Fla.); M. Rusomaroff (Indianapolis); R. Pacheco (Little Rock, Ark.); J. Weigenan, (Minneapolis); M. DiTommaso (Pittsburgh); S. Perez (San Francisco); A. Sorley (Seattle); A. Esquivel (San Antonio, Tex.); S. Thomas (Tampa, Fla.); A. Morgan, K. Zadina (Tucson, Ariz.); L. Cole (West Los Angeles); J. Maggio (Hines, Ill.); R. Thomas (Memphis, Tenn.); J. Bannister (West Roxbury, Mass.); Executive Committee — E. McFalls (Chair), H. Ward (Co-Chair), C. Jaenicke, T. Moritz, S. Goldman, W. Krupski, F. Littooy, D. Reda; Data and Safety Monitoring Board — N. Hertzer, B.J. Gersh, F. Grover, R. Chappell.
- References
References
1
Hertzer NR ,Young JR ,Kramer JR , et al. Routine coronary angiography prior to elective aortic reconstruction: results of selective myocardial revascularization in patients with peripheral vascular disease. Arch Surg 1979;114:1336-1344
Web of Science | Medline2
Goldman L ,Caldera DL ,Nussbaum SR , et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977;297:845-850
Full Text | Web of Science | Medline3
Detsky AS ,Abrams HB ,McLaughlin JR , et al. Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med 1986;1:211-219
CrossRef | Web of Science | Medline4
Eagle KA ,Coley CM ,Newell JB , et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989;110:859-866
Web of Science | Medline5
Criqui MH ,Langer RD ,Fronek A , et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-386
Full Text | Web of Science | Medline6
American College of Physicians
Web of Science | Medline7
Eagle KA ,Berger PB ,Calkins H , et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 2002;39:542-553
CrossRef | Web of Science | Medline8
Pierpont G ,Moritz T ,Goldman S , et al. Disparate opinions regarding indications for coronary artery revascularization prior to elective vascular surgery. Am J Cardiol 2004;94:1124-1128
CrossRef | Web of Science | Medline9
Hertzer NR ,Young JR ,Bevern EG , et al. Late results of coronary bypass in patients with peripheral vascular disease. II. Five-year survival according to sex, hypertension, and diabetes. Cleve Clin J Med 1987;54:15-23
Web of Science | Medline10
Rihal CS ,Eagle KA ,Mickel MC ,Foster ED ,Sopko G ,Gersh BJ . Surgical therapy for coronary artery disease among patients with combined coronary artery and peripheral vascular disease. Circulation 1995;91:46-53
Web of Science | Medline11
Mesh CL ,Cmolik BL ,Van Heekeren DW , et al. Coronary bypass in vascular patients: a relatively high-risk procedure. Ann Vasc Surg 1997;11:612-619
CrossRef | Web of Science | Medline12
McFalls EO ,Ward HB ,Krupski WC , et al. Prophylactic coronary artery revascularization for elective vascular surgery: study design. Control Clin Trials 1999;20:297-308
CrossRef | Medline13
Lee TH ,Marcantonio ER ,Mangione CM , et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043-1049
Web of Science | Medline14
Shaw LJ ,Eagle KA ,Gersh BJ ,Miller DD . Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery. J Am Coll Cardiol 1996;27:787-798
CrossRef | Web of Science | Medline15
Hassan SA ,Hlatky MA ,Boothroyd DB , et al. Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Med 2001;110:260-266
CrossRef | Web of Science | Medline16
The Bypass Angioplasty Revascularization Investigation (BARI) Investigators
Full Text | Web of Science | Medline17
Krupski WC ,Layug EL ,Reilly LM ,Rapp JH ,Mangano DT . Comparison of cardiac morbidity between aortic and infrainguinal operations. J Vasc Surg 1992;15:354-365
CrossRef | Web of Science | Medline18
Kaluza GL ,Joseph J ,Lee JR ,Raizner ME ,Raizner AE . Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000;35:1288-1294
CrossRef | Web of Science | Medline19
Coronary Artery Surgery Study (CASS): a randomized trial of coronary artery bypass surgery: survival data. Circulation 1983;68:939-950
CrossRef | Web of Science | Medline20
McFalls EO ,Doliszny KM ,Grund F ,Chute E ,Chesler E . Angina and persistent exercise thallium defects: independent risk factors in elective vascular surgery. J Am Coll Cardiol 1993;21:1347-1352
CrossRef | Web of Science | Medline21
Mangano DT ,Layug EL ,Wallace A ,Tateo I . Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996;335:1713-1720[Erratum, N Engl J Med 1997;336:1039.]
Full Text | Web of Science | Medline22
Poldermans D ,Boersma E ,Bax JJ , et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med 1999;341:1789-1794
Full Text | Web of Science | Medline23
Ellis SG ,Hertzer NR ,Young JR ,Brener S . Angiographic correlates of cardiac death and myocardial infarction complicating major nonthoracic vascular surgery. Am J Cardiol 1996;77:1126-1128
CrossRef | Web of Science | Medline
- Citing Articles (290)
Citing Articles
1
Glenn N. Levine, Eric R. Bates, James C. Blankenship, Steven R. Bailey, John A. Bittl, Bojan Cercek, Charles E. Chambers, Stephen G. Ellis, Robert A. Guyton, Steven M. Hollenberg, Umesh N. Khot, Richard A. Lange, Laura Mauri, Roxana Mehran, Issam D. Moussa, Debabrata Mukherjee, Brahmajee K. Nallamothu, Henry H. Ting, Alice K. Jacobs, Jeffrey L. Anderson, Nancy Albert, Mark A. Creager, Steven M. Ettinger, Robert A. Guyton, Jonathan L. Halperin, Judith S. Hochman, Frederick G. Kushner, E. Magnus Ohman, William Stevenson, Clyde W. Yancy. (2012) 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: Executive Summary. Catheterization and Cardiovascular Interventions 79:3, 453-495
CrossRef2
Michel Tendera, Victor Aboyans, Marie-Louise Bartelink, Iris Baumgartner, Denis Clément, Jean-Philippe Collet, Alberto Cremonesi, Marco De Carlo, Raimund Erbel, F. Gerry R. Fowkes, Magda Heras, Serge Kownator, Erich Minar, Jan Ostergren, Don Poldermans, Vincent Riambau, Marco Roffi, Joachim Röther, Horst Sievert, Marc van Sambeek, Thomas Zeller. (2012) Guía de práctica clíníca de la ESC sobre diagnóstico y tratamiento de las enfermedades arteriales periféricas. Revista Española de Cardiología 65:2, 172.e1-172.e57
CrossRef3
Pompilio Faggiano, Stefano Bonardelli, Stefania De Feo, Mariangela Valota, Silvia Frattini, Edoardo Cervi, Cristina Guadrini, Stefano M. Giulini, Livio Dei Cas. (2012) Preoperative Cardiac Evaluation and Perioperative Cardiac Therapy in Patients Undergoing Open Surgery for Abdominal Aortic Aneurysms: Effects on Cardiovascular Outcome. Annals of Vascular Surgery 26:2, 156-165
CrossRef4
Angela M. Bader. (2012) Advances in Preoperative Risk Assessment and Management. Current Problems in Surgery 49:1, 11-40
CrossRef5
Louis W Wang, Magid A Fahim, Andrew Hayen, Ruth L Mitchell, Laura Baines, Stephen Lord, Jonathan C Craig, Angela C Webster, Louis W Wang. 2011. Cardiac testing for coronary artery disease in potential kidney transplant recipients. .
CrossRef6
Mital Desai, Kurinchi Selvan Gurusamy, Hossein Ghanbari, George Hamilton, Alexander Marcus Seifalian, Mital Desai. 2011. Remote ischaemic preconditioning versus no remote ischaemic preconditioning for vascular and endovascular surgical procedures. .
CrossRef7
B. C. Flynn, W. J. Vernick, J. E. Ellis. (2011) -Blockade in the perioperative management of the patient with cardiac disease undergoing non-cardiac surgery. British Journal of Anaesthesia 107:suppl 1, i3-i15
CrossRef8
N. Diehm, J. Schmidli, C. Setacci, J.-B. Ricco, G. de Donato, F. Becker, H. Robert-Ebadi, P. Cao, H.H. Eckstein, P. De Rango, M. Teraa, F.L. Moll, F. Dick, A.H. Davies, M. Lepäntalo, J. Apelqvist. (2011) Chapter III: Management of Cardiovascular Risk Factors and Medical Therapy. European Journal of Vascular and Endovascular Surgery 42, S33-S42
CrossRef9
, , M. Tendera, V. Aboyans, M.-L. Bartelink, I. Baumgartner, D. Clement, J.-P. Collet, A. Cremonesi, M. De Carlo, R. Erbel, F. G. R. Fowkes, M. Heras, S. Kownator, E. Minar, J. Ostergren, D. Poldermans, V. Riambau, M. Roffi, J. Rother, H. Sievert, M. van Sambeek, T. Zeller, , J. Bax, A. Auricchio, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, D. Poldermans, B. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, A. Torbicki, A. Vahanian, S. Windecker, , P. Kolh, A. Torbicki, S. Agewall, A. Blinc, M. Bulvas, F. Cosentino, T. De Backer, A. Gottsater, D. Gulba, T. J. Guzik, B. Jonsson, G. Kesmarky, A. Kitsiou, W. Kuczmik, M. L. Larsen, J. Madaric, J.-L. Mas, J. J. V. McMurray, A. Micari, M. Mosseri, C. Muller, R. Naylor, B. Norrving, O. Oto, T. Pasierski, P.-F. Plouin, F. Ribichini, J.-B. Ricco, L. Ruilope, J.-P. Schmid, U. Schwehr, B. G. M. Sol, M. Sprynger, C. Tiefenbacher, C. Tsioufis, H. Van Damme. (2011) ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries * The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). European Heart Journal 32:22, 2851-2906
CrossRef10
Karina Rando, Claus U. Niemann, Pilar Taura, John Klinck. (2011) Optimizing cost-effectiveness in perioperative care for liver transplantation: A model for low- to medium-income countries. Liver Transplantation 17:11, 1247-1278
CrossRef11
Derek P. Nathan, Clayton J. Brinster, Benjamin M. Jackson, Grace J. Wang, Jeffrey P. Carpenter, Ronald M. Fairman, Edward Y. Woo. (2011) Predictors of decreased short- and long-term survival following open abdominal aortic aneurysm repair. Journal of Vascular Surgery 54:5, 1237-1243
CrossRef12
Glenn N. Levine, Eric R. Bates, James C. Blankenship, Steven R. Bailey, John A. Bittl, Bojan Cercek, Charles E. Chambers, Stephen G. Ellis, Robert A. Guyton, Steven M. Hollenberg, Umesh N. Khot, Richard A. Lange, Laura Mauri, Roxana Mehran, Issam D. Moussa, Debabrata Mukherjee, Brahmajee K. Nallamothu, Henry H. Ting. (2011) 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary. Journal of the American College of Cardiology
CrossRef13
Glenn N. Levine, Eric R. Bates, James C. Blankenship, Steven R. Bailey, John A. Bittl, Bojan Cercek, Charles E. Chambers, Stephen G. Ellis, Robert A. Guyton, Steven M. Hollenberg, Umesh N. Khot, Richard A. Lange, Laura Mauri, Roxana Mehran, Issam D. Moussa, Debabrata Mukherjee, Brahmajee K. Nallamothu, Henry H. Ting. (2011) 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. Journal of the American College of Cardiology
CrossRef14
Sonoko Saito, Atsushi Takagi, Fumio Kurokawa, Kyomi Ashihara, Nobuhisa Hagiwara. (2011) Usefulness of tissue Doppler echocardiography to predict perioperative cardiac events in patients undergoing noncardiac surgery. Heart and Vessels
CrossRef15
Zuzana Motovska. (2011) Management of Antiplatelet Therapy inPatients at Risk for Coronary StentThrombosis Undergoing Non-Cardiac Surgery. Drugs 71:14, 1797-1806
CrossRef16
Erik J. Bakker, Niels J.C. Ravensbergen, Don Poldermans. (2011) Perioperative cardiac evaluation, monitoring, and risk reduction strategies in noncardiac surgery patients. Current Opinion in Critical Care 17:5, 409-415
CrossRef17
M. R. Kahn, A. Fallahi, M. C. Kim, R. Esquitin, M. J. Robbins. (2011) Coronary Artery Disease in a Large Renal Transplant Population: Implications for Management. American Journal of Transplantationno-no
CrossRef18
J. Aalten, S. A. Peeters, M. J. van der Vlugt, A. J. Hoitsma. (2011) Is standardized cardiac assessment of asymptomatic high-risk renal transplant candidates beneficial?. Nephrology Dialysis Transplantation 26:9, 3006-3012
CrossRef19
Aviv Tuttnauer, Yuval Meroz, Giora Landesberg. (2011) Risk to and resilience of the coronary heart disease patient during surgery. Current Opinion in Critical Care 17:4, 358-361
CrossRef20
H.- J. Priebe. (2011) Preoperative cardiac management of the patient for non-cardiac surgery: an individualized and evidence-based approach. British Journal of Anaesthesia 107:1, 83-96
CrossRef21
J.-M. Fichelle. (2011) Comment améliorer le pronostic des pontages infrapoplités ?. Journal des Maladies Vasculaires 36:4, 228-236
CrossRef22
Emiliano Angeloni, Giovanni Melina, Umberto Benedetto, Simone Refice, Paolo Bianchi, Cesare Quarto, Riccardo Sinatra, John R. Pepper. (2011) Statins Improve Outcome in Isolated Heart Valve Operations: A Propensity Score Analysis of 3,217 Patients. The Annals of Thoracic Surgery 92:1, 68-73
CrossRef23
Matthias Bock, Christian J. Wiedermann, Johann Motsch, Gerhard Fritsch, Markus Paulmichl. (2011) Minimizing cardiac risk in perioperative practice – interdisciplinary pharmacological approaches. Wiener klinische Wochenschrift 123:13-14, 393-407
CrossRef24
Nicholas Marston, Jorge Brenes, Santiago Garcia, Michael Kuskowski, Selcuk Adabag, Steven Santilli, Edward O. McFalls. (2011) Peak postoperative troponin levels outperform preoperative cardiac risk indices as predictors of long-term mortality after vascular surgery. Journal of Critical Care
CrossRef25
Bertram L. Kasiske, Ajay K. Israni, Jon J. Snyder, Alexa Camarena. (2011) Design Considerations and Feasibility for a Clinical Trial to Examine Coronary Screening Before Kidney Transplantation (COST). American Journal of Kidney Diseases 57:6, 908-916
CrossRef26
E. Blommers, M. Klimek, K.A. Hartholt, T.J.M. Cammen, J. Klein, P.G. Noordzij. (2011) Perioperative care of the older patient. Zeitschrift für Gerontologie und Geriatrie 44:3, 187-191
CrossRef27
Masha Livhits, Melinda Maggard Gibbons, Christian de Virgilio, Jessica B. O'Connell, Michael J. Leonardi, Clifford Y. Ko, David S. Zingmond. (2011) Coronary Revascularization after Myocardial Infarction Can Reduce Risks of Noncardiac Surgery. Journal of the American College of Surgeons 212:6, 1018-1026
CrossRef28
Masha Livhits, Clifford Y. Ko, Michael J. Leonardi, David S. Zingmond, Melinda Maggard Gibbons, Christian de Virgilio. (2011) Risk of Surgery Following Recent Myocardial Infarction. Annals of Surgery 253:5, 857-864
CrossRef29
Stephen G. Ellis, Mehdi H. Shishehbor, Samir R. Kapadia, A. Michael Lincoff, Ravi Nair, Patrick L. Whitlow, Christopher T. Bajzer, Leslie L. Cho, E. Murat Tuzcu, Russell Raymond, Patrick Vargo, Rebecca Cunningham, Sandra J. Dushman-Ellis. (2011) Enhanced Prediction of Mortality After Percutaneous Coronary Intervention by Consideration of General and Neurological Indicators. JACC: Cardiovascular Interventions 4:4, 442-448
CrossRef30
Rita Katznelson, W. Scott Beattie. (2011) Perioperative Smoking Risk. Anesthesiology 114:4, 734-736
CrossRef31
Suneetha Ramani Moonesinghe, Michael Gerard Mythen, Michael Patrick William Grocott. (2011) High-Risk Surgery. Anesthesia & Analgesia 112:4, 891-901
CrossRef32
Louis W. Wang, Magid A. Fahim, Andrew Hayen, Ruth L. Mitchell, Stephen W. Lord, Laura A. Baines, Jonathan C. Craig, Angela C. Webster. (2011) Cardiac Testing for Coronary Artery Disease in Potential Kidney Transplant Recipients: A Systematic Review of Test Accuracy Studies. American Journal of Kidney Diseases 57:3, 476-487
CrossRef33
Tarif Khair, Bobby Garcia, Subhash Banerjee, Emmanouil S. Brilakis. (2011) Contemporary approaches to perioperative management of coronary stents and to preoperative coronary revascularization: a survey of 374 interventional cardiologists. Cardiovascular Revascularization Medicine 12:2, 99-104
CrossRef34
Joshua J Augustine, Kenneth A Bodziak, Aparna Padiyar, James A Schulak, Donald E Hricik. 2011. Kidney and Pancreas Transplantation. , 129-170.
CrossRef35
Todd J. Smaka, Miguel Cobas, Omaida C. Velazquez, David A. Lubarsky. (2011) Perioperative Management of Endovascular Abdominal Aortic Aneurysm Repair: Update 2010. Journal of Cardiothoracic and Vascular Anesthesia 25:1, 166-176
CrossRef36
Chris Dudley, Paul Harden. (2011) Renal Association Clinical Practice Guideline on the Assessment of the Potential Kidney Transplant Recipient. Nephron Clinical Practice 118:s1, c209-c224
CrossRef37
Manabu Shiraishi, Atsushi Yamaguchi, Koichi Yuri, Kazunari Nemoto, Kazuhiro Naito, Kenichiro Noguchi, Hideo Adachi. (2011) Treatment for Ischemic Heart Disease as a Comorbidity of Leriche Syndrome. Japanese Journal of Cardiovascular Surgery 40:3, 86-88
CrossRef38
E. Quénet, D. Huynh, L. Trémelot, J. Marty. (2011) Exploraciones cardíacas preoperatorias en cirugía no cardíaca. EMC - Anestesia-Reanimación 37:2, 1-9
CrossRef39
Glenn N. Levine, Eric R. Bates, James C. Blankenship, Steven R. Bailey, John A. Bittl, Bojan Cercek, Charles E. Chambers, Stephen G. Ellis, Robert A. Guyton, Steven M. Hollenberg, Umesh N. Khot, Richard A. Lange, Laura Mauri, Roxana Mehran, Issam D. Moussa, Debabrata Mukherjee, Brahmajee K. Nallamothu, Henry H. Ting, Alice K. Jacobs, Jeffrey L. Anderson, Nancy Albert, Mark A. Creager, Steven M. Ettinger, Robert A. Guyton, Jonathan L. Halperin, Judith S. Hochman, Frederick G. Kushner, E. Magnus Ohman, William Stevenson, Clyde W. Yancy. (2011) 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. Catheterization and Cardiovascular Interventionsn/a-n/a
CrossRef40
Vivek Arora, Vic Velanovich, William Alarcon. (2011) Preoperative assessment of cardiac risk and perioperative cardiac management in noncardiac surgery. International Journal of Surgery 9:1, 23-28
CrossRef41
Isaac Lynch, Daniel A. Emmert, Michael H. Wall. (2011) Perioperative Considerations and Management in Patients with Intravascular Stents. Advances in Anesthesia 29:1, 85-112
CrossRef42
Santiago Garcia, James E. Rider, Thomas E. Moritz, Gordon Pierpont, Steven Goldman, Greg C. Larsen, Kendrick Shunk, Fred Littooy, Steven Santilli, Joseph Rapp, Domenic J. Reda, Herbert B. Ward, Edward O. McFalls. (2011) Preoperative coronary artery revascularization and long-term outcomes following abdominal aortic vascular surgery in patients with abnormal myocardial perfusion scans: A subgroup analysis of the coronary artery revascularization prophylaxis trial. Catheterization and Cardiovascular Interventions 77:1, 134-141
CrossRef43
Guilherme L. Bub, Roy K. Greenberg, Tara M. Mastracci, Matthew J. Eagleton, Giuseppe Panuccio, Adrian V. Hernandez, Manuel D. Cerqueira. (2011) Perioperative cardiac events in endovascular repair of complex aortic aneurysms and association with preoperative studies. Journal of Vascular Surgery 53:1, 21-27.e2
CrossRef44
E. Qu
net, D. Huynh, L. Tr
CrossRef45
Farouk Mookadam, Shawn D Carpenter, Venkata R Thota, Steven Cha, Panupong Jiamsripong, Mohsen S Alharthi, Charanjit S Rihal, Martin D Abel. (2011) Risk of adverse events after coronary artery bypass graft and subsequent noncardiac surgery. Future Cardiology 7:1, 69-75
CrossRef46
F.L. Moll, J.T. Powell, G. Fraedrich, F. Verzini, S. Haulon, M. Waltham, J.A. van Herwaarden, P.J.E. Holt, J.W. van Keulen, B. Rantner, F.J.V. Schlösser, F. Setacci, J.-B. Ricco. (2011) Management of Abdominal Aortic Aneurysms Clinical Practice Guidelines of the European Society for Vascular Surgery. European Journal of Vascular and Endovascular Surgery 41, S1-S58
CrossRef47
Syed A Raza, Wanda M Popescu, Ion S Jovin. (2010) Perioperative stent thrombosis. Interventional Cardiology 2:6, 821-828
CrossRef48
A. Tung. (2010) Anaesthetic considerations with the metabolic syndrome. British Journal of Anaesthesia 105:Supplement 1, i24-i33
CrossRef49
Chin-Leng Poh, Pei Ho, Chi-Hang Lee. (2010) Noncardiac surgery following percutaneous coronary intervention. Interventional Cardiology 2:6, 841-850
CrossRef50
Andrew Friedrich, Tarek Helmy. (2010) Prevention of Perioperative Myocardial Infarction. International Anesthesiology Clinics 47:4, 13-36
CrossRef51
Kok-Yang Tan, Fumio Konishi, Lawrence Tan, Wui-Kin Chin, Hean-Yee Ong, Phyllis Tan. (2010) Optimizing the management of elderly colorectal surgery patients. Surgery Today 40:11, 999-1010
CrossRef52
Panagiotis Kougias, Carlos F. Bechara, Faisal Bakaeen, Danny Chu, Peter H. Lin. (2010) Impact of transfusion policy on acute coronary syndrome after major vascular reconstruction. The American Journal of Surgery 200:5, 606-609
CrossRef53
Jeffrey H Wang, Bertram L Kasiske. (2010) Screening and management of pretransplant cardiovascular disease. Current Opinion in Nephrology and Hypertension 19:6, 586-591
CrossRef54
Paul Wojciechowski. (2010) Perioperative Optimization of the Heart Failure Patient. International Anesthesiology Clinics 47:4, 121-135
CrossRef55
, , W. Wijns, P. Kolh, N. Danchin, C. Di Mario, V. Falk, T. Folliguet, S. Garg, K. Huber, S. James, J. Knuuti, J. Lopez-Sendon, J. Marco, L. Menicanti, M. Ostojic, M. F. Piepoli, C. Pirlet, J. L. Pomar, N. Reifart, F. L. Ribichini, M. J. Schalij, P. Sergeant, P. W. Serruys, S. Silber, M. Sousa Uva, D. Taggart, , A. Vahanian, A. Auricchio, J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, M. Tendera, P. E. Vardas, P. Widimsky, , P. Kolh, O. Alfieri, J. Dunning, S. Elia, P. Kappetein, U. Lockowandt, G. Sarris, P. Vouhe, , P. Kearney, L. von Segesser, S. Agewall, A. Aladashvili, D. Alexopoulos, M. J. Antunes, E. Atalar, A. Brutel de la Riviere, A. Doganov, J. Eha, J. Fajadet, R. Ferreira, J. Garot, J. Halcox, Y. Hasin, S. Janssens, K. Kervinen, G. Laufer, V. Legrand, S. A. M. Nashef, F.-J. Neumann, K. Niemela, P. Nihoyannopoulos, M. Noc, J. J. Piek, J. Pirk, Y. Rozenman, M. Sabate, R. Starc, M. Thielmann, D. J. Wheatley, S. Windecker, M. Zembala. (2010) Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal 31:20, 2501-2555
CrossRef56
Arthur W. Wallace, Selwyn Au, Brian A. Cason. (2010) Association of the Pattern of Use of Perioperative β-Blockade and Postoperative Mortality. Anesthesiology 113:4, 794-805
CrossRef57
Daniel J. Bertges, Philip P. Goodney, Yuanyuan Zhao, Andres Schanzer, Brian W. Nolan, Donald S. Likosky, Jens Eldrup-Jorgensen, Jack L. Cronenwett. (2010) The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients. Journal of Vascular Surgery 52:3, 674-683.e3
CrossRef58
Jan-Peter van Kuijk, Michiel T. Voute, Willem-Jan Flu, Olaf Schouten, Michel Chonchol, Sanne E. Hoeks, Eric E. Boersma, Hence J.M. Verhagen, Jeroen J. Bax, Don Poldermans. (2010) The efficacy and safety of clopidogrel in vascular surgery patients with immediate postoperative asymptomatic troponin T release for the prevention of late cardiac events: Rationale and design of the Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echo-VII (DECREASE-VII) trial. American Heart Journal 160:3, 387-393
CrossRef59
Ronald J. Krone. (2010) Managing Coronary Artery Disease in the Cancer Patient. Progress in Cardiovascular Diseases 53:2, 149-156
CrossRef60
David E. Winchester, Xuerong Wen, Lola Xie, Anthony A. Bavry. (2010) Evidence of Pre-Procedural Statin Therapy. Journal of the American College of Cardiology 56:14, 1099-1109
CrossRef61
Nicola Troisi, Walter Dorigo, Patrizia Lo Sapio, Giovanni Pratesi, Raffaele Pulli, Gian Franco Gensini, Carlo Pratesi. (2010) Preoperative Cardiac Assessment in Patients Undergoing Aortic Surgery: Analysis of Factors Affecting the Cardiac Outcomes. Annals of Vascular Surgery 24:6, 733-740
CrossRef62
Loren F. Hiratzka, George L. Bakris, Joshua A. Beckman, Robert M. Bersin, Vincent F. Carr, Donald E. Casey, Kim A. Eagle, Luke K. Hermann, Eric M. Isselbacher, Ella A. Kazerooni, Nicholas T. Kouchoukos, Bruce W. Lytle, Dianna M. Milewicz, David L. Reich, Souvik Sen, Julie A. Shinn, Lars G. Svensson, David M. Williams, Alice K. Jacobs, Sidney C. Smith, Jeffery L. Anderson, Cynthia D. Adams, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, Robert A. Guyton, Jonathan L. Halperin, Sharon A. Hunt, Harlan M. Krumholz, Frederick G. Kushner, Bruce W. Lytle, Rick Nishimura, Richard L. Page, Barbara Riegel, William G. Stevenson, Lynn G. Tarkington, Clyde W. Yancy. (2010) 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: Executive Summary. Catheterization and Cardiovascular Interventions 76:2, E43-E86
CrossRef63
Martin Czerny, Martin Funovics, Marek Ehrlich, Michael Hoebartner, Gottfried Sodeck, Julia Dumfarth, Maria Schoder, Andrzej Juraszek, Tomasz Dziodzio, Christian Loewe, Daniel Zimpfer, David Reineke, Michael Grimm. (2010) Risk Factors of Mortality in Different Age Groups After Thoracic Endovascular Aortic Repair. The Annals of Thoracic Surgery 90:2, 534-538
CrossRef64
Nicola Troisi, Walter Dorigo, Patrizia Lo Sapio, Giovanni Pratesi, Raffaele Pulli, Gian Franco Gensini, Carlo Pratesi. (2010) Bilan cardiaque préopératoire des patients pour chirurgie aortique : analyse des facteurs influençant les suites cardiaques. Annales de Chirurgie Vasculaire 24:6, 800-807
CrossRef65
Michael C. Stoner, Dorian J. deFreitas. (2010) Process of care for carotid endarterectomy: Perioperative medical management. Journal of Vascular Surgery 52:1, 223-231
CrossRef66
W.-J. Flu, O. Schouten, J.-P. van Kuijk, D. Poldermans. (2010) Perioperative Cardiac Damage in Vascular Surgery Patients. European Journal of Vascular and Endovascular Surgery 40:1, 1-8
CrossRef67
José J.G. De Lima, Luis H.W. Gowdak, Flavio J. De Paula, Rodolfo L. Arantes, Luis E. Ianhez, Jose A.F. Ramires, Eduardo M. Krieger. (2010) Influence of coronary artery disease assessment and treatment in the incidence of cardiac events in renal transplant recipients. Clinical Transplantation 24:4, 474-480
CrossRef68
Santiago Garcia, Sara T.N. Murray, Thomas E. Moritz, Gordon Pierpont, Steven Goldman, Greg C. Larsen, Fred Littooy, Herbert B. Ward, Edward O. McFalls. (2010) Les lésions coronaires symptomatiques exigeant une intervention coronaire percutanée après chirurgie vasculaire se compliquent souvent de resténoses intra-stents dans les stent nus. Annales de Chirurgie Vasculaire 24:5, 651-656
CrossRef69
Shailja V. Parikh, Ashish Parikh, Emmanouil S. Brilakis, Subhash Banerjee. (2010) Simultaneous dual coronary very late stent thrombosis following noncardiac surgery. Cardiovascular Revascularization Medicine 11:3, 172-174
CrossRef70
A. Cassar, D. Poldermans, C. S. Rihal, B. J. Gersh. (2010) The management of combined coronary artery disease and peripheral vascular disease. European Heart Journal 31:13, 1565-1572
CrossRef71
Daniel Eberli, Pierre-Guy Chassot, Tullio Sulser, Charles Marc Samama, Jean Mantz, Alain Delabays, Donat R. Spahn. (2010) Urological Surgery and Antiplatelet Drugs After Cardiac and Cerebrovascular Accidents. The Journal of Urology 183:6, 2128-2136
CrossRef72
Tara M. Mastracci, Roy K. Greenberg, Adrian V. Hernandez, Catherine Morales. (2010) Defining high risk in endovascular aneurysm repair. Journal of Vascular Surgery 51:5, 1088-1095.e1
CrossRef73
Mike Seddon, Nick Curzen. (2010) CORONARY REVASCULARISATION IN CHRONIC KIDNEY DISEASE PART 1: STABLE CORONARY ARTERY DISEASE. Journal of Renal Care 36, 106-117
CrossRef74
Mital Desai, Kurinchi Selvan Gurusamy, Hossein Ghanbari, George Hamilton, Alexander Seifalian, Mital Desai. 2010. Remote ischaemic preconditioning versus no remote ischaemic preconditioning for vascular and endovascular surgical procedures. .
CrossRef75
Thomas W. Barrett, Kathleen Newton, Caroline Koudelka, Motomi Mori, LeAnn Radcliffe. (2010) Impact of combination medical therapy on mortality in vascular surgery patients. Journal of Hospital Medicine 5:4, 218-225
CrossRef76
Patrick B. Mark, Rajan K. Patel, Alan G. Jardine. (2010) Screening for Coronary Artery Disease Before Renal Transplantation—Rational or Rationing?. Transplantation 89:7, 807-808
CrossRef77
Loren F. Hiratzka, George L. Bakris, Joshua A. Beckman, Robert M. Bersin, Vincent F. Carr, Donald E. Casey, Kim A. Eagle, Luke K. Hermann, Eric M. Isselbacher, Ella A. Kazerooni, Nicholas T. Kouchoukos, Bruce W. Lytle, Dianna M. Milewicz, David L. Reich, Souvik Sen, Julie A. Shinn, Lars G. Svensson, David M. Williams. (2010) 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease: Executive Summary. Journal of the American College of Cardiology 55:14, 1509-1544
CrossRef78
José Jayme G. De Lima, Luís Henrique W. Gowdak, Flávio Jota de Paula, Rodolfo L. Arantes, André Luís Veiga de Oliveira, Jose Antonio F. Ramires, Luiz Antonio M. César, Eduardo M. Krieger. (2010) Treatment of Coronary Artery Disease in Hemodialysis Patients Evaluated for Transplant—A Registry Study. Transplantation 89:7, 845-850
CrossRef79
Loren F. Hiratzka, George L. Bakris, Joshua A. Beckman, Robert M. Bersin, Vincent F. Carr, Donald E. Casey, Kim A. Eagle, Luke K. Hermann, Eric M. Isselbacher, Ella A. Kazerooni, Nicholas T. Kouchoukos, Bruce W. Lytle, Dianna M. Milewicz, David L. Reich, Souvik Sen, Julie A. Shinn, Lars G. Svensson, David M. Williams. (2010) 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease. Journal of the American College of Cardiology 55:14, e27-e129
CrossRef80
Balachundhar Subramaniam, Kathirvel Subramaniam. (2010) Not All Perioperative Myocardial Infarctions Can Be Prevented with Preoperative Revascularization. Anesthesiology 112:3, 524-526
CrossRef81
Edo Kaluski. (2010) Prophylactic Pre-Operative Coronary Revascularization. Journal of the American College of Cardiology 55:13, 1396-1397
CrossRef82
Raja C. Pullatt, David I. Silverman, Gary V. Heller. (2010) Are Long-Term Outcomes of Medium- to High-Risk Patients Undergoing Vascular Surgery Affected by the Ischemia Evaluation Strategy?. Journal of the American College of Cardiology 55:13, 1397-1398
CrossRef83
David Rott. (2010) Prophylactic Coronary Angiography Improves Outcome After Major Vascular Surgery. Journal of the American College of Cardiology 55:13, 1396
CrossRef84
Wael Galal, Sanne E. Hoeks, Willem Jan Flu, Jan Peter van Kuijk, Dustin Goei, Tjebbe Galema, Corstiaan den Uil, Yvette R. B. M. van Gestel, Jeroen J. Bax, Hence J. M. Verhagen, Don Poldermans. (2010) Relation between Preoperative and Intraoperative New Wall Motion Abnormalities in Vascular Surgery Patients. Anesthesiology 112:3, 557-566
CrossRef85
Alessandro Brunelli. (2010) Risk Assessment for Pulmonary Resection. Seminars in Thoracic and Cardiovascular Surgery 22:1, 2-13
CrossRef86
G. Illuminati, J.-B. Ricco, C. Greco, E. Mangieri, F. Calio', G. Ceccanei, M.A. Pacilè, M. Schiariti, G. Tanzilli, F. Barillà, V. Paravati, G. Mazzesi, F. Miraldi, L. Tritapepe. (2010) Systematic Preoperative Coronary Angiography and Stenting Improves Postoperative Results of Carotid Endarterectomy in Patients with Asymptomatic Coronary Artery Disease: A Randomised Controlled Trial. European Journal of Vascular and Endovascular Surgery 39:2, 139-145
CrossRef87
Don Poldermans, Jeroen J Bax, Eric Boersma, Stefan De Hert, Erik Eeckhout, Gerry Fowkes, Bulent Gorenek, Michael G Hennerici, Bernard Iung, Malte Kelm, Keld Per Kjeldsen, Steen Dalby Kristensen, Jose Lopez-Sendon, Paolo Pelosi, François Philippe, Luc Pierard, Piotr Ponikowski, Jean-Paul Schmid, Olav FM Sellevold, Rosa Sicari, Greet Van den Berghe, Frank Vermassen. (2010) Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. European Journal of Anaesthesiology 27:2, 92-137
CrossRef88
Wanda M Popescu. (2010) Perioperative management of the patient with a coronary stent. Current Opinion in Anaesthesiology 23:1, 109-115
CrossRef89
B. M. Biccard, R. N. Rodserth. (2010) A reply. Anaesthesia 65:2, 211-211
CrossRef90
Kazuyoshi Kaneko, Makoto Ito, Toshiyasu Takanashi, Eiji Hashizume, Kazuya Owashi, Hisashi Kaneko, Yoshihiro Ide, Masaki Oguma. (2010) Computed Tomography and Scintigraphy vs. Cardiac Catheterization for Coronary Disease Screening Prior to Noncardiac Surgery. Internal Medicine 49:16, 1703-1710
CrossRef91
Krista L. Lentine, Frank P. Hurst, Rahul M. Jindal, Todd C. Villines, Jeffrey S. Kunz, Christina M. Yuan, Paul J. Hauptman, Kevin C. Abbott. (2010) Cardiovascular Risk Assessment Among Potential Kidney Transplant Candidates: Approaches and Controversies. American Journal of Kidney Diseases 55:1, 152-167
CrossRef92
Takeshi Kimura, Takaaki Isshiki, Yasuhiko Hayashi, Shigeru Oshima, Masanobu Namura, Hitoshi Nakashima, Kazuya Kawai, Takahito Sone, Ryozo Tatami, Taiichiro Meguro, Masakiyo Nobuyoshi, Kazuaki Mitsudo. (2010) Incidence and outcome of surgical procedures after sirolimus-eluting stent implantation: a report from the j-Cypher registry. Cardiovascular Intervention and Therapeutics 25:1, 29-39
CrossRef93
Hideki Miyachi, Jun Tanabe, Eitaro Kodani, Yusuke Hosokawa, Mitsunobu Kitamura, Asako Sasaki, Michio Ogano, Kunito Shiiba, Hisato Takagi, Takuya Umemoto, Yoshiki Kusama, Kyoichi Mizuno. (2010) Coronary artery revascularization before peripheral vascular surgery in patients with peripheral arterial disease. Cardiovascular Intervention and Therapeutics 25:1, 11-17
CrossRef94
Miklós D. Kertai, János Gál. (2009) Preoperative coronary revascularization for the reduction of perioperative ischemic complications in patients undergoing major vascular surgery. Interventional Medicine and Applied Science 1:1, 12-19
CrossRef95
Don Poldermans, Jeroen J. Bax, Eric Boersma, Stefan de Hert, Erik Eeckhout, Gerry Fowkes, Bulent Gorenek, Michael G. Hennerici, Bernard Iung, Malte Kelm, Keld Per Kjeldsen, Steen Dalby Kristensen, José López-Sendón, Paolo Pelosi, François Philippe, Luc Pierard, Piotr Ponikowski, Jean-Paul Schmid, Olav F.M. Sellevold, Rosa Sicari, Greet Van den Berghe, Frank Vermassen. (2009) Guía de práctica clínica para la valoración del riesgo cardiaco preoperatorio y el manejo cardiaco perioperatorio en la cirugía no cardiaca. Revista Española de Cardiología 62:12, 1467.e1-1467.e56
CrossRef96
Walter A. Tan. (2009) Noncardiac surgery after coronary senting or angioplasty. Catheterization and Cardiovascular Interventions 74:6, 844-845
CrossRef97
, D. Poldermans, J. J. Bax, E. Boersma, S. De Hert, E. Eeckhout, G. Fowkes, B. Gorenek, M. G. Hennerici, B. Iung, M. Kelm, K. P. Kjeldsen, S. D. Kristensen, J. Lopez-Sendon, P. Pelosi, F. Philippe, L. Pierard, P. Ponikowski, J.-P. Schmid, O. F.M. Sellevold, R. Sicari, G. Van den Berghe, F. Vermassen, , S. E. Hoeks, I. Vanhorebeek, , A. Vahanian, A. Auricchio, J. J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, K. McGregor, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, M. Tendera, P. Vardas, P. Widimsky, , R. De Caterina, S. Agewall, N. Al Attar, F. Andreotti, S. D. Anker, G. Baron-Esquivias, G. Berkenboom, L. Chapoutot, R. Cifkova, P. Faggiano, S. Gibbs, H. S. Hansen, L. Iserin, C. W. Israel, R. Kornowski, N. M. Eizagaechevarria, M. Pepi, M. Piepoli, H. J. Priebe, M. Scherer, J. Stepinska, D. Taggart, M. Tubaro. (2009) Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). European Heart Journal 30:22, 2769-2812
CrossRef98
Lee A. Fleisher, Joshua A. Beckman, Kenneth A. Brown, Hugh Calkins, Elliot L. Chaikof, Kirsten E. Fleischmann, William K. Freeman, James B. Froehlich, Edward K. Kasper, Judy R. Kersten, Barbara Riegel, John F. Robb. (2009) 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade Incorporated Into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery. Journal of the American College of Cardiology 54:22, e13-e118
CrossRef99
E. Schmid, M. Nowak, K. Unertl, P. Rosenberger. (2009) Intraoperative Echokardiographie. Der Anaesthesist 58:11, 1123-1135
CrossRef100
B. M. Biccard, R. N. Rodseth. (2009) A meta-analysis of the prospective randomised trials of coronary revascularisation before noncardiac vascular surgery with attention to the type of coronary revascularisation performed. Anaesthesia 64:10, 1105-1113
CrossRef101
Elliot L. Chaikof, David C. Brewster, Ronald L. Dalman, Michel S. Makaroun, Karl A. Illig, Gregorio A. Sicard, Carlos H. Timaran, Gilbert R. Upchurch, Frank J. Veith. (2009) The care of patients with an abdominal aortic aneurysm: The Society for Vascular Surgery practice guidelines. Journal of Vascular Surgery 50:4, S2-S49
CrossRef102
James B. Froehlich, Lee A. Fleisher. (2009) Noncardiac Surgery in the Patient with Heart Disease. Medical Clinics of North America 93:5, 995-1016
CrossRef103
HELEN L PILMORE. (2009) Review article: Coronary artery stenoses: Detection and revascularization in renal disease. Nephrology 14:6, 537-543
CrossRef104
Mario Monaco, Paolo Stassano, Luigi Di Tommaso, Paolo Pepino, Arturo Giordano, Giovanni B. Pinna, Gabriele Iannelli, Giuseppe Ambrosio. (2009) Systematic Strategy of Prophylactic Coronary Angiography Improves Long-Term Outcome After Major Vascular Surgery in Medium- to High-Risk Patients. Journal of the American College of Cardiology 54:11, 989-996
CrossRef105
Giora Landesberg, Morris Mosseri. (2009) Prophylactic Pre-Operative Coronary Revascularization. Journal of the American College of Cardiology 54:11, 997-998
CrossRef106
Freddie M. Williams, James D. Bergin. (2009) Cardiac Screening Before Noncardiac Surgery. Surgical Clinics of North America 89:4, 747-762
CrossRef107
&NA;. (2009) Preoperative and Intraoperative Predictors of Cardiac Adverse Events After General, Vascular, and Urological Surgery. Survey of Anesthesiology 53:4, 180-181
CrossRef108
Martin J London. (2009) Cardiovascular problems in noncardiac surgery. Current Opinion in Critical Care 15:4, 333-341
CrossRef109
Brett M. Wertman, Victor Y. Cheng, Saibal Kar, Heidi Gransar, Ryan A. Berg, Hursh Naik, Rajendra Makkar, John D. Friedman, Jay N. Schapira, Daniel S. Berman. (2009) Characterization of Complex Coronary Artery Stenosis Morphology by Coronary Computed Tomographic Angiography. JACC: Cardiovascular Imaging 2:8, 950-958
CrossRef110
J. Roggenbach, B. Böttiger, P. Teschendorf. (2009) Perioperative Myokardschäden bei nichtkardiochirurgischen Patienten. Der Anaesthesist 58:7, 665-676
CrossRef111
Amir K. Jaffer, Gerald W. Smetana, Steven Cohn, Barbara Slawski. (2009) Perioperative Medicine Update. Journal of General Internal Medicine 24:7, 863-871
CrossRef112
Sanne Hoeks, Willem-Jan Flu, Jan-Peter van Kuijk, Jeroen Bax, Don Poldermans. (2009) Cardiovascular risk assessment of the diabetic patient undergoing major noncardiac surgery. Best Practice & Research Clinical Endocrinology & Metabolism 23:3, 361-373
CrossRef113
Stefan G De Hert. (2009) Preoperative cardiovascular assessment in noncardiac surgery: an update. European Journal of Anaesthesiology 26:6, 449-457
CrossRef114
L. T. J. Hickson, Z. M. El-Zoghby, E. C. Lorenz, M. D. Stegall, A. S. Jaffe, F. G. Cosio. (2009) Patient Survival After Kidney Transplantation: Relationship to Pretransplant Cardiac Troponin T Levels. American Journal of Transplantation 9:6, 1354-1361
CrossRef115
Stefan G. De Hert. (2009) Preoperative Electrocardiograms. Anesthesiology 110:6, 1205-1206
CrossRef116
George A. Beller. (2009) Noninvasive screening for coronary atherosclerosis and silent ischemia in asymptomatic high-risk populations. Current Cardiovascular Imaging Reports 2:3, 213-222
CrossRef117
Willem-Jan Flu, Jan-Peter van Kuijk, Tamara Winkel, Sanne Hoeks, Jeroen Bax, Don Poldermans. (2009) Prevention of acute coronary events in noncardiac surgery: β-blocker therapy and coronary revascularization. Expert Review of Cardiovascular Therapy 7:5, 521-532
CrossRef118
Thomas H. Marwick, Helen Branagan, Bala Venkatesh, Simon Stewart. (2009) Use of a nurse-led intervention to optimize beta-blockade for reducing cardiac events after major noncardiac surgery. American Heart Journal 157:4, 784-790
CrossRef119
Olaf Schouten, Jan-Peter van Kuijk, Willem-Jan Flu, Tamara A. Winkel, Gijs M.J.M. Welten, Eric Boersma, Hence J.M. Verhagen, Jeroen J. Bax, Don Poldermans. (2009) Long-Term Outcome of Prophylactic Coronary Revascularization in Cardiac High-Risk Patients Undergoing Major Vascular Surgery (from the Randomized DECREASE-V Pilot Study). The American Journal of Cardiology 103:7, 897-901
CrossRef120
W Scott Beattie, Keyvan Karkouti, Duminda N. Wijeysundera, Gordon Tait. (2009) Risk Associated with Preoperative Anemia in Noncardiac Surgery. Anesthesiology 110:3, 574-581
CrossRef121
D. Poldermans, O. Schouten, J. Bax, T. A. Winkel. (2009) Reducing cardiac risk in non-cardiac surgery: evidence from the DECREASE studies. European Heart Journal Supplements 11:Suppl A, A9-A14
CrossRef122
Srinivas Mantha, Michael F. Roizen, Joseph Foss, John E. Ellis. (2009) Cardiac Troponin Surveillance After Abdominal Aortic Surgery. Anesthesia & Analgesia 108:3, 1047-1048
CrossRef123
Willem-Jan Flu, Sanne E. Hoeks, Jan-Peter Kuijk, Jeroen J. Bax, Don Poldermans. (2009) Treatment recommendations to prevent myocardial ischemia and infarction in patients undergoing vascular surgery. Current Treatment Options in Cardiovascular Medicine 11:1, 33-44
CrossRef124
R. N. Rodseth. (2009) B type natriuretic peptide - a diagnostic breakthrough in peri-operative cardiac risk assessment?. Anaesthesia 64:2, 165-178
CrossRef125
Kristóf Rácz, Tamás Tiszai-Szűcs, János Gál, Miklós Kertai D.. (2009) Preoperatív revascularisatio nagy kockázatú, érsebészeti betegeknél. Orvosi Hetilap 150:8, 341-352
CrossRef126
Helge Möllmann, Holger M. Nef, Christian W. Hamm, Albrecht Elsässer. (2009) How to manage patients with need for antiplatelet therapy in the setting of (un-)planned surgery. Clinical Research in Cardiology 98:1, 8-15
CrossRef127
Joshua S. Adler, Andrew D. Auerbach. 2009. Medical Complications of Head and Neck Surgery. , 55-65.
CrossRef128
Christian de Virgilio, Arezou Yaghoubian, Alex Nguyen, Roger J. Lewis, Christine Dauphine, Grant Sarkisyan, Darrell W. Harrington. (2009) Peripheral Vascular Surgery Using Targeted Beta Blockade Reduces Perioperative Cardiac Event Rate. Journal of the American College of Surgeons 208:1, 14-20
CrossRef129
Stewart R. Walsh, Tjun Y. Tang, Umar Sadat, Michael E. Gaunt. (2009) Remote ischemic preconditioning in major vascular surgery. Journal of Vascular Surgery 49:1, 240-243
CrossRef130
Sachin Kheterpal, Michael O’Reilly, Michael J. Englesbe, Andrew L. Rosenberg, Amy M. Shanks, Lingling Zhang, Edward D. Rothman, Darrell A. Campbell, Kevin K. Tremper. (2009) Preoperative and Intraoperative Predictors of Cardiac Adverse Events after General, Vascular, and Urological Surgery. Anesthesiology 110:1, 58-66
CrossRef131
W. K. Freeman, R. J. Gibbons. (2009) Perioperative Cardiovascular Assessment of Patients Undergoing Noncardiac Surgery. Mayo Clinic Proceedings 84:1, 79-90
CrossRef132
Terrence L. Trentman, David M. Rosenfeld, David R. Danielson, Susan G. Hagstrom. (2008) Drug-Eluting Stents: Patient Understanding of the Risks of Premature Cessation of Antiplatelet Drugs. Journal of Cardiothoracic and Vascular Anesthesia 22:6, 806-810
CrossRef133
Bobbie Jean Sweitzer. (2008) Preoperative screening, evaluation, and optimization of the patientʼs medical status before outpatient surgery. Current Opinion in Anaesthesiology 21:6, 711-718
CrossRef134
Yusuke Hosokawa, Hitoshi Takano, Asako Aoki, Toru Inami, Michio Ogano, Nobuaki Kobayashi, Jun Tanabe, Hiroyuki Yokoyama, Takayoshi Kato, Hisato Takagi, Takuya Umemoto, Morimasa Takayama, Kyoichi Mizuno. (2008) Management of Coronary Artery Disease in Patients Undergoing Elective Abdominal Aortic Aneurysm Open Repair. Clinical Cardiology 31:12, 580-585
CrossRef135
Matthias Bock, Christian J. Wiedermann. (2008) Perioperative Risikoreduktion – eine interdisziplinäre Herausforderung. Wiener Medizinische Wochenschrift 158:21-22, 590-594
CrossRef136
Molly Carnes, Claudia Morrissey, Stacie E. Geller. (2008) Women's Health and Women's Leadership in Academic Medicine: Hitting the Same Glass Ceiling?. Journal of Women's Health 17:9, 1453-1462
CrossRef137
Jean Marie Ruddy, William Yarbrough, Thomas Brothers, Jacob Robison, Bruce Elliott. (2008) Abdominal Aortic Aneurysm and Significant Coronary Artery Disease: Strategies and Options. Southern Medical Journal 101:11, 1113-116
CrossRef138
Edit Szomják, Henrietta Dér, György Kerekes, Katalin Veres, Judit Tóth, Sándor Olvasztó, Csaba Herczku, Pál Soltész. (2008) Multiplex obliteratív érbetegség. Kihívás a diagnosztikában és a kezelésben. Orvosi Hetilap 149:45, 2135-2140
CrossRef139
Stephen K. Sigworth. (2008) Preoperative evaluation of hospitalized patients. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine 75:5, 442-448
CrossRef140
Ezio Faglia, Giacomo Clerici, Maurizio Caminiti, Antonella Quarantiello, Vincenzo Curci, Alberto Morabito. (2008) Advantages of myocardial revascularization after admission for critical limb ischemia in diabetic patients with coronary artery disease: data of a cohort of 564 consecutive patients. Journal of Cardiovascular Medicine 9:10, 1030-1036
CrossRef141
SANTIAGO GARCIA, EDWARD O. MCFALLS, STEVEN GOLDMAN, GREG C. LARSEN, FRED LITTOOY, THOMAS E. MORITZ, DOMENIC J. REDA, HERBERT B. WARD, KENDRICK SHUNK, BRACK HATTLER. (2008) Diagnostic Coronary Angiography in Patients with Peripheral Arterial Disease: A Sub-study of the Coronary Artery Revascularization Prophylaxis Trial. Journal of Interventional Cardiology 21:5, 369-374
CrossRef142
Santiago Garcia, Thomas E. Moritz, Herbert B. Ward, Gordon Pierpont, Steve Goldman, Greg C. Larsen, Fred Littooy, William Krupski, Lizy Thottapurathu, Domenic J. Reda, Edward O. McFalls. (2008) Usefulness of Revascularization of Patients With Multivessel Coronary Artery Disease Before Elective Vascular Surgery for Abdominal Aortic and Peripheral Occlusive Disease. The American Journal of Cardiology 102:7, 809-813
CrossRef143
Santiago Garcia, Edward O. McFalls. (2008) Preoperative Coronary Revascularization in High-Risk Patients Undergoing Vascular Surgery. Anesthesia & Analgesia 107:4, 1442-1443
CrossRef144
Peter Tinits. (2008) Preoperative Coronary Revascularization in High-Risk Patients Undergoing Vascular Surgery. Anesthesia & Analgesia 107:4, 1442
CrossRef145
Jeroen Aalten, Ellen K. Hoogeveen, Joke I. Roodnat, Willem Weimar, George F. Borm, Johan W. de Fijter, Andries J. Hoitsma. (2008) Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and death. Transplant International 21:10, 985-991
CrossRef146
Keun Her, ChangWoo Choi, YoungWoo Park, HwaKyun Shin, YongSoon Won. (2008) Association d'une artériopathie oblitérante des membres inférieurs et d'une coronaropathie asymptomatique : stratégie de prise en charge. Annales de Chirurgie Vasculaire 22:5, 704-712
CrossRef147
Keun Her, ChangWoo Choi, YoungWoo Park, HwaKyun Shin, YongSoon Won. (2008) Concomitant Peripheral Artery Disease and Asymptomatic Coronary Artery Disease: A Management Strategy. Annals of Vascular Surgery 22:5, 649-656
CrossRef148
Marie-Claude Parent, Stéphane Rinfret. (2008) The unresolved issues with risk stratification and management of patients with coronary artery disease undergoing major vascular surgery. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 55:8, 542-556
CrossRef149
M. Petzoldt, J. Kähler, A.E. Goetz, P. Friederich. (2008) Perioperative medikamentöse Kardioprotektion. Der Anaesthesist 57:7, 655-669
CrossRef150
Victor Cheng, Ariel Gutstein, Arik Wolak, Yasuyuki Suzuki, Damini Dey, Heidi Gransar, Louise E.J. Thomson, Sean W. Hayes, John D. Friedman, Daniel S. Berman. (2008) Moving Beyond Binary Grading of Coronary Arterial Stenoses on Coronary Computed Tomographic Angiography. JACC: Cardiovascular Imaging 1:4, 460-471
CrossRef151
Anthony A Bavry, Deepak L Bhatt. (2008) Appropriate use of drug-eluting stents: balancing the reduction in restenosis with the concern of late thrombosis. The Lancet 371:9630, 2134-2143
CrossRef152
Magnus A. Garrioch, A.C. Pichel. (2008) Reducing the risk of vascular surgery. Current Anaesthesia & Critical Care 19:3, 128-137
CrossRef153
Aslan T. Turer, Debra A. Schwinn. (2008) Understanding the Transition to Acute Illness: The Promise of Perioperative Genomics. Journal of Cardiovascular Translational Research 1:2, 171-173
CrossRef154
Don Poldermans, Sanne E. Hoeks, Harm H. Feringa. (2008) Pre-Operative Risk Assessment and Risk Reduction Before Surgery. Journal of the American College of Cardiology 51:20, 1913-1924
CrossRef155
Z.A. Ali, C.J. Callaghan, A.A. Ali, A.Y. Sheikh, A. Akhtar, A. Pavlovic, S.A. Reza Nouraei, D.P. Dutka, M.E. Gaunt. (2008) Perioperative Myocardial Injury after Elective Open Abdominal Aortic Aneurysm Repair Predicts Outcome. European Journal of Vascular and Endovascular Surgery 35:4, 413-419
CrossRef156
Cristina Tita, Vanji Karthikeyan, Alice Stroe, Gordon Jacobsen, Karthik Ananthasubramaniam. (2008) Stress Echocardiography for Risk Stratification in Patients with End-Stage Renal Disease Undergoing Renal Transplantation. Journal of the American Society of Echocardiography 21:4, 321-326
CrossRef157
Christiane P. Tiefenbacher. (2008) Abdominal aortic aneurysm repair in cardiac high risk patients – medication, surgery or stent?. Clinical Research in Cardiology 97:4, 215-221
CrossRef158
Hasan H. Dosluoglu, Jiping Wang, Leslie DeFranks-Anain, Miguel Rainstein, Nader D. Nader. (2008) A simple subclassification of American Society of Anesthesiology III patients undergoing peripheral revascularization based on functional capacity. Journal of Vascular Surgery 47:4, 766-773
CrossRef159
Gijs M.J.M. Welten, Olaf Schouten, Sanne E. Hoeks, Michel Chonchol, Radosav Vidakovic, Ron T. van Domburg, Jeroen J. Bax, Marc R.H.M. van Sambeek, Don Poldermans. (2008) Long-Term Prognosis of Patients With Peripheral Arterial Disease. Journal of the American College of Cardiology 51:16, 1588-1596
CrossRef160
Bradley G. Hammill, Lesley H. Curtis, Elliott Bennett-Guerrero, Christopher M. OʼConnor, James G. Jollis, Kevin A. Schulman, Adrian F. Hernandez. (2008) Impact of Heart Failure on Patients Undergoing Major Noncardiac Surgery. Anesthesiology 108:4, 559-567
CrossRef161
Paul J. Grant, David H. Wesorick. (2008) Perioperative Medicine for the Hospitalized Patient. Medical Clinics of North America 92:2, 325-348
CrossRef162
Miklos D. Kertai. (2008) Preoperative Coronary Revascularization in High-Risk Patients Undergoing Vascular Surgery: A Core Review. Anesthesia & Analgesia 106:3, 751-758
CrossRef163
William Vernick, Lee A. Fleisher. (2008) Risk stratification. Best Practice & Research Clinical Anaesthesiology 22:1, 1-21
CrossRef164
Dawn E. Jaroszewski, Joseph Huh, Danny Chu, S. Chris Malaisrie, Anthony D. Riffel, Howard S. Gordon, Xing Li Wang, Faisal Bakaeen. (2008) Utility of detailed preoperative cardiac testing and incidence of post-thoracotomy myocardial infarction. The Journal of Thoracic and Cardiovascular Surgery 135:3, 648-655
CrossRef165
Luciano Babuin, Vlad C. Vasile, Jose A. Rio Perez, Jorge R. Alegria, High-Seng Chai, Bekele Afessa, Allan S. Jaffe. (2008) Elevated cardiac troponin is an independent risk factor for short- and long-term mortality in medical intensive care unit patients. Critical Care Medicine 36:3, 759-765
CrossRef166
Giora Landesberg, Morris Mosseri. (2008) PRO: Preoperative Coronary Revascularization in High-Risk Patients Undergoing Vascular Surgery. Anesthesia & Analgesia 106:3, 759-763
CrossRef167
Santiago Garcia, Edward O. McFalls. (2008) CON: Preoperative Coronary Revascularization in High-Risk Patients Undergoing Vascular Surgery. Anesthesia & Analgesia 106:3, 764-766
CrossRef168
Lee A. Fleisher, Joshua A. Beckman, Kenneth A. Brown, Hugh Calkins, Elliott Chaikof, Kirsten E. Fleischmann, William K. Freeman, James B. Froehlich, Edward K. Kasper, Judy R. Kersten, Barbara Riegel, John F. Robb, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Elliott M. Antman, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, David P. Faxon, Valentin Fuster, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Bruce W. Lytle, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Lynn G. Tarkington, Clyde W. Yancy. (2008) ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary. Anesthesia & Analgesia 106:3, 685-712
CrossRef169
R. Sicari, P. Nihoyannopoulos, A. Evangelista, J. Kasprzak, P. Lancellotti, D. Poldermans, J.-U. Voigt, J. L. Zamorano, . (2008) Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). European Journal of Echocardiography 9:4, 415-437
CrossRef170
Geraldine Daumerie, Lee A Fleisher. (2008) Perioperative ??-blocker and statin therapy. Current Opinion in Anaesthesiology 21:1, 60-65
CrossRef171
Colleen Christmas, Roy C. Ziegelstein, Lee A. Fleisher. 2008. Perioperative Cardiovascular Evaluation and Treatment of Elderly Patients Undergoing Noncardiac Surgery. , 769-810.
CrossRef172
Elisabeth Mahla, Norbert Watzinger, Wolfgang Toller. (2008) The Future for B-type Natriuretic Peptide in Preoperative Assessment. Anesthesiology 108:2, 333-334
CrossRef173
Steven L. Cohn. (2008) Preoperative Cardiac Evaluation of Lung Resection Candidates. Thoracic Surgery Clinics 18:1, 45-59
CrossRef174
HOWARD H. WEITZ. 2008. Noncardiac Surgery in the Patient with Cardiovascular Disease: Preoperative Evaluation and Perioperative Care. , 157-247.
CrossRef175
Bertram L. Kasiske, Ajay K. Israni. 2008. Cardiovascular Complications after Renal Transplantation. , 469-491.
CrossRef176
Hye Won Lee. (2008) Perioperative management for patients undergoing noncardiac surgery after percutaneous coronary intervention. Korean Journal of Anesthesiology 55:1, 1
CrossRef177
S.J. Howell, R.S. Vohra. (2007) Perioperative Management of Patients Undergoing Non-cardiac Vascular Surgery. European Journal of Vascular and Endovascular Surgery 34:6, 625-631
CrossRef178
Ronit Lavi, Shahar Lavi, Elena Daghini, Lilach O. Lerman. (2007) New Frontiers in the Evaluation of Cardiac Patients for Noncardiac Surgery. Anesthesiology 107:6, 1018-1028
CrossRef179
D. Bolliger, M. D. Seeberger, G. A. L. Lurati Buse, P. Christen, L. Gürke, M. Filipovic. (2007) Randomized clinical trial of moxonidine in patients undergoing major vascular surgery. British Journal of Surgery 94:12, 1477-1484
CrossRef180
Enzo Ballotta, Giuseppe Da Giau, Carmelo Militello, Oreste Terranova, Antonio Piccoli. (2007) Major Elective Surgery for Vascular Disease in Patients Aged 80 or More: Perioperative (30-Day) Outcomes. Annals of Vascular Surgery 21:6, 772-779
CrossRef181
Thomas R. McLean, Jennifer McGoldrick, Sheryl Fox, Chris C. Haller, Jane Arevalo. (2007) Training general surgery residents to avoid postoperative cardiac events. The American Journal of Surgery 194:5, 633-638
CrossRef182
Margherita Cinello, Gaetano Nucifora, Massimo Bertolissi, Luigi P Badano, Claudio Fresco, Nevio Gonano, Paolo M Fioretti. (2007) American College of Cardiology/American Heart Association perioperative assessment guidelines for noncardiac surgery reduces cardiologic resource utilization preserving a favourable clinical outcome. Journal of Cardiovascular Medicine 8:11, 882-888
CrossRef183
Stefano Lucreziotti, Serena Conforti, Francesca Carletti, Giulia Santaguida, Stefano Meda, Federico Raveglia, Fabrizio Tundo, Tiziana Panigalli, Maria L. Biondi, Maurizio Mezzetti, Cesare Fiorentini. (2007) Elevaciones de la troponina I cardiaca tras la cirugía torácica. Incidencia y correlaciones con las características clínicas basales, la proteína C reactiva y los parámetros perioperatorios. Revista Española de Cardiología 60:11, 1159-1166
CrossRef184
Srinivas Mantha, Joseph Foss, John E. Ellis, Michael F. Roizen. (2007) Intense Cardiac Troponin Surveillance for Long-Term Benefits Is Cost-Effective in Patients Undergoing Open Abdominal Aortic Surgery: A Decision Analysis Model. Anesthesia & Analgesia 105:5, 1346-1356
CrossRef185
Sanne E. Hoeks, Wilma J. M. Scholte op Reimer, Mattie J. Lenzen, Hero van Urk, Paul J. G. Jörning, Eric Boersma, Maarten L. Simoons, Jeroen J. Bax, Don Poldermans. (2007) Guidelines for Cardiac Management in Noncardiac Surgery Are Poorly Implemented in Clinical Practice. Anesthesiology 107:4, 537-544
CrossRef186
Víctor G. Dávila-Román. (2007) Valoración del riesgo cardiaco de la cirugía no cardiaca. Revista Española de Cardiología 60:10, 1005-1009
CrossRef187
Edward O. McFalls, Herbert B. Ward, Thomas E. Moritz, Fred Littooy, Steve Santilli, Joseph Rapp, Greg Larsen, Domenic J. Reda. (2007) Clinical factors associated with long-term mortality following vascular surgery: Outcomes from The Coronary Artery Revascularization Prophylaxis (CARP) Trial. Journal of Vascular Surgery 46:4, 694-700
CrossRef188
Olaf Schouten, Jeroen J. Bax, Don Poldermans. (2007) Evaluación del riesgo coronario en el manejo de pacientes sometidos a cirugía vascular no cardiaca. Revista Española de Cardiología 60:10, 1083-1091
CrossRef189
Lee A. Fleisher, Joshua A. Beckman, Kenneth A. Brown, Hugh Calkins, Elliott L. Chaikof, Kirsten E. Fleischmann, William K. Freeman, James B. Froehlich, Edward K. Kasper, Judy R. Kersten, Barbara Riegel, John F. Robb, Sidney C. Smith, Alice K. Jacobs, Cynthia D. Adams, Jeffrey L. Anderson, Elliott M. Antman, Christopher E. Buller, Mark A. Creager, Steven M. Ettinger, David P. Faxon, Valentin Fuster, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Bruce W. Lytle, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel, Lynn G. Tarkington, Clyde W. Yancy. (2007) ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery. Journal of the American College of Cardiology 50:17, e159-e242
CrossRef190
Lee A. Fleisher, Joshua A. Beckman, Kenneth A. Brown, Hugh Calkins, Elliott Chaikof, Kirsten E. Fleischmann, William K. Freeman, James B. Froehlich, Edward K. Kasper, Judy R. Kersten, Barbara Riegel, John F. Robb. (2007) ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary. Journal of the American College of Cardiology 50:17, 1707-1732
CrossRef191
O. Schouten, D. Poldermans. (2007) Cardiac risk in non-cardiac surgery. British Journal of Surgery 94:10, 1185-1186
CrossRef192
Donat R. Spahn, Pierre-Guy Chassot, Michael Zaugg. (2007) Pragmatic Treatment versus Elaborative but Incomplete Testing. Anesthesiology 107:4, 526-529
CrossRef193
André Coelho Marques, Pai Ching Yu, Daniela Calderaro, Danielle Menosi Gualandro, Bruno Caramelli. (2007) High-Risk Patients Undergoing Major Vascular Surgery: To Operate or Not to Operate?. Journal of the American College of Cardiology 50:14, 1398-1399
CrossRef194
Emmanouil S. Brilakis, Subhash Banerjee, Peter B. Berger. (2007) The risk of drug-eluting stent thrombosis with noncardiac surgery. Current Cardiology Reports 9:5, 406-411
CrossRef195
S A. Reza Nouraei, Chadwan Al-Yaghchi, Guri S. Sandhu, Dino A. Giussani, Patrick Doyle, Peter M. Clarke. (2007) Incidence and Significance of Myocardial Injury After Surgical Treatment of Head and Neck Cancer. The Laryngoscope 117:9, 1581-1587
CrossRef196
R. Heine, B. Rau, R. Willenbrock. (2007) Präoperatives Management: Verbesserungsmöglichkeiten kardiopulmonaler Erkrankungen im Alter. Der Onkologe 13:9, 792-800
CrossRef197
Elise Y. W. Wong, Herenia P. Lawrence, David T. Wong. (2007) The effects of prophylactic coronary revascularization or medical management on patient outcomes after noncardiac surgery - a meta-analysis. Canadian Journal of Anesthesia/Journal canadien d'anesthésie 54:9, 705-717
CrossRef198
R SMITH, S YOUNG, I GREER. (2007) The parturient with coronary heart disease. International Journal of Obstetric Anesthesia
CrossRef199
Lee A. Fleisher. (2007) The Preoperative Electrocardiogram. Annals of Surgery 246:2, 171-172
CrossRef200
S. Silber, M. Borggrefe, M. Böhm, H.M. Hoffmeister, R. Dietz, G. Ertl, G. Heusch. (2007) Positionspapier der DGK zur Wirksamkeit und Sicherheit von Medikamente freisetzenden Koronarstents (DES). Der Kardiologe 1:2, 84-111
CrossRef201
Thomas W. Barrett, Motomi Mori, David De Boer. (2007) Association of ambulatory use of statins and beta-blockers with long-term mortality after vascular surgery. Journal of Hospital Medicine 2:4, 241-252
CrossRef202
S. C. Gibson, C. J. Payne, D. S. Byrne, C. Berry, H. J. Dargie, D. B. Kingsmore. (2007) B-type natriuretic peptide predicts cardiac morbidity and mortality after major surgery. British Journal of Surgery 94:7, 903-909
CrossRef203
John E. Ellis, Avery Tung, Hubert Lee, Kristen Kasza. (2007) Predictors of Perioperative β-Blockade Use in Vascular Surgery: A Mail Survey of United States Anesthesiologists. Journal of Cardiothoracic and Vascular Anesthesia 21:3, 330-336
CrossRef204
William J. Mauermann, Kent H. Rehfeldt, Malcolm R. Bell, Stuart M. Lowson. (2007) Percutaneous Coronary Interventions and Antiplatelet Therapy in the Perioperative Period. Journal of Cardiothoracic and Vascular Anesthesia 21:3, 436-442
CrossRef205
Olaf Schouten, Jeroen J Bax, Don Poldermans. (2007) Management of patients with cardiac stents undergoing noncardiac surgery. Current Opinion in Anaesthesiology 20:3, 274-278
CrossRef206
Mathias H Winkler, Eric K Mayer, David Hrouda, Patrick Doyle. (2007) Therapy insight: prophylaxis, monitoring and treatment of perioperative myocardial ischemia with emphasis on urological surgery. Nature Clinical Practice Urology 4:6, 333-340
CrossRef207
Pierre-Guy Chassot, Alain Delabays, Donat R. Spahn. (2007) Perioperative use of anti-platelet drugs. Best Practice & Research Clinical Anaesthesiology 21:2, 241-256
CrossRef208
Elisabeth Mahla, Anneliese Baumann, Peter Rehak, Norbert Watzinger, Martin N. Vicenzi, Robert Maier, Kurt Tiesenhausen, Helfried Metzler, Wolfgang Toller. (2007) N-Terminal Pro-brain Natriuretic Peptide Identifies Patients at High Risk for Adverse Cardiac Outcome after Vascular Surgery. Anesthesiology 106:6, 1088-1095
CrossRef209
I. A. Scott, R. S. Lodge, D. M. Russell. (2007) Evidence-based guide to perioperative medicine. Internal Medicine Journal 37:6, 389-401
CrossRef210
Emmanouil S. Brilakis, Subhash Banerjee, Peter B. Berger. (2007) Perioperative Management of Patients With Coronary Stents. Journal of the American College of Cardiology 49:22, 2145-2150
CrossRef211
O. Schouten, J.J. Bax, D. Poldermans. (2007) Cardiac Troponins as a Risk Stratification Tool for Patients with Chronic Critical Limb Ischemia. European Journal of Vascular and Endovascular Surgery 33:6, 708-709
CrossRef212
Shunei Saito, Kazuaki Shirota, Hajime Nakamura, Kenji Sakaguchi, Katsuo Ozawa, Yuichi Ueda. (2007) Two cases of colonic necrosis following aortoiliac surgery due to coronary-induced cardiogenic shock. General Thoracic and Cardiovascular Surgery 55:5, 208-211
CrossRef213
Don Poldermans, Olaf Schouten, Radosav Vidakovic, Jeroen J. Bax, Ian R. Thomson, Sanne E. Hoeks, Harm H.H. Feringa, Martin Dunkelgrün, Peter de Jaegere, Alexander Maat, Marc R.H.M. van Sambeek, Miklos D. Kertai, Eric Boersma. (2007) A Clinical Randomized Trial to Evaluate the Safety of a Noninvasive Approach in High-Risk Patients Undergoing Major Vascular Surgery. Journal of the American College of Cardiology 49:17, 1763-1769
CrossRef214
Steven L. Cohn, Andrew D. Auerbach. (2007) Preoperative cardiac risk stratification 2007: Evolving evidence, evolving strategies. Journal of Hospital Medicine 2:3, 174-180
CrossRef215
Judy R. Kersten, Lee A. Fleisher. (2007) Drug-eluting Coronary Stents. Anesthesiology 106:5, 898-900
CrossRef216
C. Naughton, R. O. Feneck. (2007) The impact of age on 6-month survival in patients with cardiovascular risk factors undergoing elective non-cardiac surgery. International Journal of Clinical Practice 61:5, 768-776
CrossRef217
Donna L. Mercado, David Y. Ling, Gerald W. Smetana. (2007) Perioperative Cardiac Evaluation: Novel Interventions and Clinical Challenges. Southern Medical Journal 100:5, 486-492
CrossRef218
Mauro Moscucci, Noah Jones. (2007) Coronary Revascularization Before Noncardiac Vascular Surgery. Journal of the American College of Cardiology 49:17, 1770-1771
CrossRef219
O. Schouten, M. Dunkelgrun, H.H.H. Feringa, N.F.M. Kok, R. Vidakovic, J.J. Bax, D. Poldermans. (2007) Myocardial Damage in High-risk Patients Undergoing Elective Endovascular or Open Infrarenal Abdominal Aortic Aneurysm Repair. European Journal of Vascular and Endovascular Surgery 33:5, 544-549
CrossRef220
Mario Abbud-Filho, Patricia L. Adams, Josefina Alber??, Carl Cardella, Jeremy Chapman, Pierre Cochat, Fernando Cosio, Gabriel Danovitch, Connie Davis, Robert S. Gaston, Atul Humar, Lawrence G. Hunsicker, Michelle A. Josephson, Bertram Kasiske, G??nter Kirste, Alan Leichtman, Stephen Munn, Gregorio T. Obrador, Annika Tibell, Jonas Wadstr??m, Martin Zeier, Francis L. Delmonico. (2007) A Report of the Lisbon Conference on the Care of the Kidney Transplant Recipient. Transplantation 83:Supplement, S1-S22
CrossRef221
Sondra Vazirani, Neil M. Paige, Aksone Nouvong, David Aungst. (2007) Evaluating and Minimizing Cardiac Risk in Surgical Patients. Clinics in Podiatric Medicine and Surgery 24:2, 261-283
CrossRef222
Jonathan A Winston. (2007) How important is screening angiography for CAS in diabetic patients awaiting transplant? A nephrologist's view. Nature Clinical Practice Cardiovascular Medicine 4:3, 134-135
CrossRef223
Nils Butte, B.W. Böttiger, P. Teschendorf. (2007) Perioperative Kardioprotektion. Der Anaesthesist 56:3, 285-298
CrossRef224
Wilbur Y.W. Lew. (2007) A Cool Heart Protected From Infarction. Journal of the American College of Cardiology 49:5, 606-607
CrossRef225
Stephen M. Salerno, Daniel W. Carlson, Eugene K. Soh, Christopher J. Lettieri. (2007) Impact of Perioperative Cardiac Assessment Guidelines on Management of Orthopedic Surgery Patients. The American Journal of Medicine 120:2, 185.e1-185.e6
CrossRef226
Fernando Alfonso, Javier Segovia, Magda Heras, Javier Bermejo. (2007) Patología arterial no coronaria: ¿de interés para el cardiólogo?. Revista Española de Cardiología 60:2, 179-183
CrossRef227
Stephen H Pennefather. (2007) Anaesthesia for oesophagectomy. Current Opinion in Anaesthesiology 20:1, 15-20
CrossRef228
B.J. Gersh. (2007) Should Major Vascular Surgery Be Delayed Because of Preoperative Cardiac Testing in Intermediate-Risk Patients Receiving Beta-Blocker Therapy With Tight Heart Rate Control?. Yearbook of Cardiology 2007, 293-295
CrossRef229
Mohammed M. Minhaj, John E Ellis. (2007) Myocardial Ischemia and Infarction. ASA Refresher Courses in Anesthesiology 35:1, 127-144
CrossRef230
Peter Alison, Andrew McKee. 2007. Surgery for Coronary Artery Disease. , 141-157.
CrossRef231
Fernando Alfonso, Javier Segovia, Magda Heras, Javier Bermejo. (2007) Non-Coronary Arterial Disease: of Interest to Cardiologists?. Revista Española de Cardiología (English Edition) 60:2, 179-183
CrossRef232
Deborah H. Kwon, Lee Goldberg. 2007. Other Topics in Cardiology Consultation. , 124-150.
CrossRef233
P.-A. Chulliat, L. Lorgis, C. Richard, C. Pernet, A.-C. Lagrost, A.-L. Merel, M. Zeller, Y. Cottin, C. Girard. (2007) Infarctus et période péri-opératoire: quel bilan? Quel traitement? Quelle surveillance?. Annales de Cardiologie et d'Angéiologie 56:1, 42-47
CrossRef234
F. Kerbaul, C. Guidon. (2007) Anestesia del paziente coronaropatico in chirurgia generale. EMC - Anestesia-Rianimazione 12:3, 1-18
CrossRef235
Atif Qasim, David Horowitz. 2007. Preoperative Cardiovascular Risk Assessment. , 90-123.
CrossRef236
L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, F.G.R. Fowkes. (2007) Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). European Journal of Vascular and Endovascular Surgery 33:1, S1-S75
CrossRef237
B.J. Gersh. (2007) Comparison of Cardiovascular Risk of Noncardiac Surgery Following Coronary Angioplasty With Versus Without Stenting. Yearbook of Cardiology 2007, 256-257
CrossRef238
L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, F.G.R. Fowkes. (2007) Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Journal of Vascular Surgery 45:1, S5-S67
CrossRef239
William R. Hiatt. 2007. Peripheral Arterial Disease. , 379-388.
CrossRef240
Darin J. Correll, Angela M. Bader, Melissa W. Hull, Cindy Hsu, Lawrence C. Tsen, David L. Hepner. (2006) Value of Preoperative Clinic Visits in Identifying Issues with Potential Impact on Operating Room Efficiency. Anesthesiology 105:6, 1254-1259
CrossRef241
Colleen Christmas, Martin A. Makary, John R. Burton. (2006) Medical Considerations in Older Surgical Patients. Journal of the American College of Surgeons 203:5, 746-751
CrossRef242
Mohamed Y. Rady. (2006) Critical care for high-risk cardiac surgery: What lies beyond?*. Critical Care Medicine 34:11, 2847-2849
CrossRef243
Gerald Gartlehner, Richard A. Hansen, Daniel Nissman, Kathleen N. Lohr, Timothy S. Carey. (2006) A simple and valid tool distinguished efficacy from effectiveness studies. Journal of Clinical Epidemiology 59:10, 1040-1048
CrossRef244
Kim A. Eagle, Wei C. Lau. (2006) Any Need for Preoperative Cardiac Testing in Intermediate-Risk Patients With Tight Beta-Adrenergic Blockade?
Editorials published in the Journal of American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.. Journal of the American College of Cardiology 48:5, 970-972
CrossRef245
Ramesh Venkataraman. (2006) Vascular surgery critical care: Perioperative cardiac optimization to improve survival. Critical Care Medicine 34:Suppl, S200-S207
CrossRef246
Herbert B. Ward, Rosemary F. Kelly, Lizy Thottapurathu, Thomas E. Moritz, Greg C. Larsen, Gordon Pierpont, Steve Santilli, Steven Goldman, William C. Krupski, Fred Littooy, Domenic J. Reda, Edward O. McFalls. (2006) Coronary Artery Bypass Grafting is Superior to Percutaneous Coronary Intervention in Prevention of Perioperative Myocardial Infarctions During Subsequent Vascular Surgery. The Annals of Thoracic Surgery 82:3, 795-801
CrossRef247
Don Poldermans, Jeroen J. Bax, Olaf Schouten, Aleksandar N. Neskovic, Bernard Paelinck, Guido Rocci, Laura van Dortmont, Anai E.S. Durazzo, Louis L.M. van de Ven, Marc R.H.M. van Sambeek, Miklos D. Kertai, Eric Boersma. (2006) Should Major Vascular Surgery Be Delayed Because of Preoperative Cardiac Testing in Intermediate-Risk Patients Receiving Beta-Blocker Therapy With Tight Heart Rate Control?. Journal of the American College of Cardiology 48:5, 964-969
CrossRef248
RAIMUND BUSLEY, WULF DIETRICH. (2006) Consequences of coronary artery stenting for non-cardiac surgery. Transfusion Alternatives in Transfusion Medicine 8:3, 151-155
CrossRef249
Ramachandra R Sista, Kavita V Ernst, Euan A Ashley. (2006) Perioperative cardiac risk: pathophysiology, assessment and management. Expert Review of Cardiovascular Therapy 4:5, 731-743
CrossRef250
M. D. Kertai, L. Bogar, J. Gal, D. Poldermans. (2006) Pre-operative coronary revascularization: an optimal therapy for high-risk vascular surgery patients?. Acta Anaesthesiologica Scandinavica 50:7, 816-827
CrossRef251
Giuseppe Papia, David Klein, Thomas F Lindsay. (2006) Intensive care of the patient following open abdominal aortic surgery. Current Opinion in Critical Care 12:4, 340-345
CrossRef252
Dawn D. Smiley, Guillermo E. Umpierrez. (2006) Perioperative Glucose Control in the Diabetic or Nondiabetic Patient. Southern Medical Journal 99:6, 580-589
CrossRef253
Amritha Raghunathan, Joseph H. Rapp, Fred Littooy, Steven Santilli, William C. Krupski, Herbert B. Ward, Lizy Thottapurathu, Thomas Moritz, Edward O. McFalls. (2006) Postoperative outcomes for patients undergoing elective revascularization for critical limb ischemia and intermittent claudication: A subanalysis of the Coronary Artery Revascularization Prophylaxis (CARP) trial. Journal of Vascular Surgery 43:6, 1175-1182
CrossRef254
Michal Barak, Ron Ben-Abraham, Yeshayahu Katz. (2006) ACC/AHA guidelines for preoperative cardiovascular evaluation for noncardiac surgery: A critical point of view. Clinical Cardiology 29:5, 195-198
CrossRef255
David Goldhill, Carl Waldmann. (2006) Excellent anaesthesia needs patient preparation and postoperative support to influence outcome. Current Opinion in Anaesthesiology 19:2, 192-197
CrossRef256
H. Pilmore. (2006) Cardiac Assessment for Renal Transplantation. American Journal of Transplantation 6:4, 659-665
CrossRef257
William C. Mackey, Lee A. Fleisher, Seema Haider, Saraih Sheikh, Joseph C. Cappelleri, Won Chan Lee, Qin Wang, Jennifer M. Stephens. (2006) Perioperative myocardial ischemic injury in high-risk vascular surgery patients: Incidence and clinical significance in a prospective clinical trial. Journal of Vascular Surgery 43:3, 533-538
CrossRef258
Olaf Schouten, Leslee J. Shaw, Eric Boersma, Jeroen J. Bax, Miklos D. Kertai, Harm H.H. Feringa, Elena Biagini, Niels F.M. Kok, Hero van Urk, Abdou Elhendy, Don Poldermans. (2006) A meta-analysis of safety and effectiveness of perioperative beta-blocker use for the prevention of cardiac events in different types of noncardiac surgery. Coronary Artery Disease 17:2, 173-179
CrossRef259
K. L. Cantlay, S. Baker, A. Parry, G. Danjoux. (2006) The impact of a consultant anaesthetist led pre-operative assessment clinic on patients undergoing major vascular surgery*. Anaesthesia 61:3, 234-239
CrossRef260
P STONE, S FLAHERTY, A ABURAHMA, S HASS, J JACKSON, J HAYES, M HOFELDT, C HAGER, M ELMORE. (2006) Factors Affecting Perioperative Mortality and Wound-Related Complications Following Major Lower Extremity Amputations. Annals of Vascular Surgery 20:2, 209-216
CrossRef261
Alan T. Hirsch, Ziv J. Haskal, Norman R. Hertzer, Curtis W. Bakal, Mark A. Creager, Jonathan L. Halperin, Loren F. Hiratzka, William R.C. Murphy, Jeffrey W. Olin, Jules B. Puschett, Kenneth A. Rosenfield, David Sacks, James C. Stanley, Lloyd M. Taylor, Christopher J. White, John White, Rodney A. White, Elliott M. Antman, Sidney C. Smith, Cynthia D. Adams, Jeffrey L. Anderson, David P. Faxon, Valentin Fuster, Raymond J. Gibbons, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Alice K. Jacobs, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel. (2006) ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): A Collaborative Report from the American Association for Vascular Surgery/Society for Vascular Surgery,
CrossRef262
Daniel G. Hackam. (2006) Perioperative β-blocker therapy in vascular surgery: Clinical update. Journal of Vascular Surgery 43:3, 632-634
CrossRef263
Alan T. Hirsch, Ziv J. Haskal, Norman R. Hertzer, Curtis W. Bakal, Mark A. Creager, Jonathan L. Halperin, Loren F. Hiratzka, William R.C. Murphy, Jeffrey W. Olin, Jules B. Puschett, Kenneth A. Rosenfield, David Sacks, James C. Stanley, Lloyd M. Taylor, Christopher J. White, John White, Rodney A. White, Elliott M. Antman, Sidney C. Smith, Cynthia D. Adams, Jeffrey L. Anderson, David P. Faxon, Valentin Fuster, Raymond J. Gibbons, Jonathan L. Halperin, Loren F. Hiratzka, Sharon A. Hunt, Alice K. Jacobs, Rick Nishimura, Joseph P. Ornato, Richard L. Page, Barbara Riegel. (2006) ACC/AHA 2005 Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): Executive Summary A Collaborative Report From the American Association for Vascular Surgery/Society for Vascular Surgery,
CrossRef264
Zara Cooper, Cesar E. Escareno, David B. Lautz. 2006. Management of Perioperative Cardiac Risk in the Bariatric Patient. , 365-380.
CrossRef265
Rosemary F. Kelly, Edward O. McFalls. (2006) Preoperative evaluation and treatment of stable cad in patients scheduled for major elective vascular surgery. Current Treatment Options in Cardiovascular Medicine 8:1, 59-66
CrossRef266
W Scott Beattie, Esam Abdelnaem, Duminda N. Wijeysundera, D Norman Buckley. (2006) A Meta-Analytic Comparison of Preoperative Stress Echocardiography and Nuclear Scintigraphy Imaging. Anesthesia & Analgesia 102:1, 8-16
CrossRef267
W FRISHMAN. (2006) Coronary-Artery Revascularization Before Elective Major Vascular SurgeryMcFalls EO, Ward HB, Moritz TE, et al (Univ of Minnesota, Minneapolis; VA Med Ctr, Hines, III; Univ of Arizona, Tucson; et al) N Engl J Med 351:2795–2804, 2004§. Yearbook of Medicine 2006, 336-337
CrossRef268
G MONETA. (2006) Coronary-Artery Revascularization Before Elective Major Vascular SurgeryMcFalls EO, Ward HB, Moritz TE, et al (Univ of Minnesota, Minneapolis; VA Med Ctr, Hines, Ill; Univ of Arizona, Tucson; et al) N Engl J Med 351:2795–2804, 2004§. Yearbook of Vascular Surgery 2006, 81-82
CrossRef269
Paul M. Maggio, Paul A. Taheri. (2005) Perioperative Issues: Myocardial Ischemia and Protection — Beta-Blockade. Surgical Clinics of North America 85:6, 1091-1102
CrossRef270
William G. Cheadle. (2005) The Veterans Affairs research program: scientific and clinical excellence relevant to veterans’ healthcare needs. The American Journal of Surgery 190:5, 655-661
CrossRef271
B. M. Biccard, J. W. Sear, P. Foëx. (2005) Statin therapy: a potentially useful peri-operative intervention in patients with cardiovascular disease. Anaesthesia 60:11, 1106-1114
CrossRef272
Olaf Schouten, Jeroen J Bax, Don Poldermans. (2005) Prevention of perioperative cardiovascular complications in non-cardiac surgery: the future role of statins. Future Cardiology 1:6, 701-704
CrossRef273
Norman R. Hertzer, Edward J. Mascha. (2005) A personal experience with factors influencing survival after elective open repair of infrarenal aortic aneurysms. Journal of Vascular Surgery 42:5, 898.e1-898.e10
CrossRef274
Bertram L. Kasiske, Mobin A. Malik, Charles A. Herzog. (2005) Risk-Stratified Screening for Ischemic Heart Disease in Kidney Transplant Candidates. Transplantation 80:6, 815-820
CrossRef275
Enrico Passamonti, Salvatore Pirelli. (2005) Reducing risk of cardiovascular events in noncardiac surgery. Expert Opinion on Pharmacotherapy 6:9, 1507-1515
CrossRef276
Peter K. Henke. (2005) Improving quality of care in vascular surgery: the tools are available now. The American Journal of Surgery 190:2, 333-337
CrossRef277
(2005) Scientific Surgery. British Journal of Surgery 92:7, 899-899
CrossRef278
(2005) Peri-operative myocardial ischaemia. Anaesthesia 60:7, 714-716
CrossRef279
D. Mergner, P. Rosenberger, K. Unertl, H. K. Eltzschig. (2005) Präoperative Evaluation und perioperatives Vorgehen bei kardialen Risikopatienten. Der Anaesthesist 54:5, 427-441
CrossRef280
Lee A. Fleisher. (2005) Strategies to Reduce Cardiac Risk in Noncardiac Surgery. Anesthesiology 102:5, 881-882
CrossRef281
(2005) Coronary Revascularization before Vascular Surgery. New England Journal of Medicine 352:14, 1492-1495
Full Text282
Barry Rubin, W Scott Beattie. (2005) Does coronary artery revascularization before major vascular surgery benefit patients with coronary artery disease?. Nature Clinical Practice Cardiovascular Medicine 2:4, 190-191
CrossRef283
Gilles Godet, Bruno Riou, Mich??le Bertrand, Marie-H??l??ne Fl??ron, Jean-Pierre Goarin, Gilles Montalescot, Pierre Coriat. (2005) Does Preoperative Coronary Angioplasty Improve Perioperative Cardiac Outcome?. Anesthesiology 102:4, 739-746
CrossRef284
J. Wacker, T. Pasch, M. C. Schaub, M. Zaugg. (2005) Perioperative Strategien zur Regulierung des Sympathikotonus. Der Anaesthesist 54:4, 303-318
CrossRef285
Janet T. Powell. (2005) Perioperative β-blockade (Pobble) for patients undergoing infrarenal vascular surgery: Results of a randomized double-blind controlled trial. Journal of Vascular Surgery 41:4, 602-609
CrossRef286
B. Zwi
CrossRef287
N Sakalihasan, R Limet, OD Defawe. (2005) Abdominal aortic aneurysm. The Lancet 365:9470, 1577-1589
CrossRef288
Edward J Norris. (2005) Perioperative Management of the Patient Undergoing Aortic Vascular Surgery. ASA Refresher Courses in Anesthesiology 33:1, 187-202
CrossRef289
Lee A Fleisher. (2005) Preoperative Assessment of the Patient with Cardiac Disease. ASA Refresher Courses in Anesthesiology 33:1, 79-88
CrossRef290
Moscucci, Mauro, Eagle, Kim A., . (2004) Coronary Revascularization before Noncardiac Surgery. New England Journal of Medicine 351:27, 2861-2863
Full Text
- Letters
